US20130172538A1 - Method for producing porous particles, porous particles, adsorbent body, and method for purifying protein - Google Patents
Method for producing porous particles, porous particles, adsorbent body, and method for purifying protein Download PDFInfo
- Publication number
- US20130172538A1 US20130172538A1 US13/821,836 US201113821836A US2013172538A1 US 20130172538 A1 US20130172538 A1 US 20130172538A1 US 201113821836 A US201113821836 A US 201113821836A US 2013172538 A1 US2013172538 A1 US 2013172538A1
- Authority
- US
- United States
- Prior art keywords
- cellulose
- adsorbent
- less
- porous particle
- porous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002245 particle Substances 0.000 title claims abstract description 314
- 239000003463 adsorbent Substances 0.000 title claims abstract description 156
- 238000000034 method Methods 0.000 title claims abstract description 68
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 46
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 229920002678 cellulose Polymers 0.000 claims abstract description 231
- 239000001913 cellulose Substances 0.000 claims abstract description 230
- 239000000243 solution Substances 0.000 claims abstract description 128
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 87
- 239000002608 ionic liquid Substances 0.000 claims abstract description 51
- 239000007788 liquid Substances 0.000 claims abstract description 50
- 239000006185 dispersion Substances 0.000 claims abstract description 42
- 239000007864 aqueous solution Substances 0.000 claims abstract description 29
- 230000001112 coagulating effect Effects 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 87
- 239000013076 target substance Substances 0.000 claims description 48
- 239000003446 ligand Substances 0.000 claims description 36
- 230000007717 exclusion Effects 0.000 claims description 19
- 238000012856 packing Methods 0.000 claims description 12
- 239000003480 eluent Substances 0.000 claims description 4
- 235000019750 Crude protein Nutrition 0.000 claims description 2
- 238000005192 partition Methods 0.000 claims 2
- 239000002904 solvent Substances 0.000 abstract description 21
- 239000000126 substance Substances 0.000 abstract description 14
- ALWXETURCOIGIZ-UHFFFAOYSA-N 1-nitropropylbenzene Chemical compound CCC([N+]([O-])=O)C1=CC=CC=C1 ALWXETURCOIGIZ-UHFFFAOYSA-N 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 235000010980 cellulose Nutrition 0.000 description 220
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 105
- 239000000203 mixture Substances 0.000 description 47
- 238000001179 sorption measurement Methods 0.000 description 38
- 239000011148 porous material Substances 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- 238000005259 measurement Methods 0.000 description 23
- 238000000746 purification Methods 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 230000003068 static effect Effects 0.000 description 18
- 239000011521 glass Substances 0.000 description 17
- 239000012046 mixed solvent Substances 0.000 description 15
- XIYUIMLQTKODPS-UHFFFAOYSA-M 1-ethyl-3-methylimidazol-3-ium;acetate Chemical compound CC([O-])=O.CC[N+]=1C=CN(C)C=1 XIYUIMLQTKODPS-UHFFFAOYSA-M 0.000 description 14
- -1 acyclic cation Chemical class 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 238000002441 X-ray diffraction Methods 0.000 description 12
- 239000003925 fat Substances 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 11
- 230000003247 decreasing effect Effects 0.000 description 10
- 230000003100 immobilizing effect Effects 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- 238000009826 distribution Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 5
- 229960002303 citric acid monohydrate Drugs 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 150000004667 medium chain fatty acids Chemical class 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 5
- 229940067157 phenylhydrazine Drugs 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- 150000004671 saturated fatty acids Chemical class 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 235000019482 Palm oil Nutrition 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 238000005056 compaction Methods 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000021323 fish oil Nutrition 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000002540 palm oil Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- QPRQEDXDYOZYLA-UHFFFAOYSA-N 2-methylbutan-1-ol Chemical compound CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- 229920000875 Dissolving pulp Polymers 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 235000019484 Rapeseed oil Nutrition 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- RJTANRZEWTUVMA-UHFFFAOYSA-N boron;n-methylmethanamine Chemical compound [B].CNC RJTANRZEWTUVMA-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 108010074605 gamma-Globulins Proteins 0.000 description 3
- 102000034238 globular proteins Human genes 0.000 description 3
- 108091005896 globular proteins Proteins 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229940057910 shea butter Drugs 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 2
- MXLMTQWGSQIYOW-UHFFFAOYSA-N 3-methyl-2-butanol Chemical compound CC(C)C(C)O MXLMTQWGSQIYOW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical group CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- AEOQMMHATQYSLZ-UHFFFAOYSA-N ethenyl ethenesulfonate Chemical compound C=COS(=O)(=O)C=C AEOQMMHATQYSLZ-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- ZOCHHNOQQHDWHG-UHFFFAOYSA-N hexan-3-ol Chemical compound CCCC(O)CC ZOCHHNOQQHDWHG-UHFFFAOYSA-N 0.000 description 2
- 239000008173 hydrogenated soybean oil Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000010699 lard oil Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000000634 powder X-ray diffraction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- HBOQXIRUPVQLKX-BBWANDEASA-N 1,2,3-trilinoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)CCCCCCC\C=C/C\C=C/CCCCC HBOQXIRUPVQLKX-BBWANDEASA-N 0.000 description 1
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- PHCASOSWUQOQAG-UHFFFAOYSA-M 1-butyl-3-methylpyridin-1-ium;chloride Chemical compound [Cl-].CCCC[N+]1=CC=CC(C)=C1 PHCASOSWUQOQAG-UHFFFAOYSA-M 0.000 description 1
- QNVRIHYSUZMSGM-LURJTMIESA-N 2-Hexanol Natural products CCCC[C@H](C)O QNVRIHYSUZMSGM-LURJTMIESA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- ALRXDIKPRCRYAU-UHFFFAOYSA-N 2-methylpropan-2-ol Chemical compound CC(C)(C)O.CC(C)(C)O ALRXDIKPRCRYAU-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- LZKGFGLOQNSMBS-UHFFFAOYSA-N 4,5,6-trichlorotriazine Chemical compound ClC1=NN=NC(Cl)=C1Cl LZKGFGLOQNSMBS-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 240000009305 Pometia pinnata Species 0.000 description 1
- 235000017284 Pometia pinnata Nutrition 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 241001261505 Undaria Species 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 238000006149 azo coupling reaction Methods 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000019869 fractionated palm oil Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 229940009600 gammagard Drugs 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N linoleic acid triglyceride Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- 229920002114 octoxynol-9 Polymers 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000011137 process chromatography Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229940093633 tricaprin Drugs 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- 229940081852 trilinolein Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 229960001947 tripalmitin Drugs 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B1/00—Preparatory treatment of cellulose for making derivatives thereof, e.g. pre-treatment, pre-soaking, activation
- C08B1/003—Preparation of cellulose solutions, i.e. dopes, with different possible solvents, e.g. ionic liquids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/16—Powdering or granulating by coagulating dispersions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
- B01J20/267—Cross-linked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/285—Porous sorbents based on polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/048—Elimination of a frozen liquid phase
- C08J2201/0482—Elimination of a frozen liquid phase the liquid phase being organic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2207/00—Foams characterised by their intended use
- C08J2207/12—Sanitary use, e.g. diapers, napkins or bandages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/02—Cellulose; Modified cellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Definitions
- the present invention relates to a method for producing a porous particle, a porous particle produced by the production method, an adsorbent containing the porous particle, and a method for purifying a protein by using the adsorbent.
- a porous particle is widely used as a carrier for an adsorbent such as an adsorbent for various chromatography and an affinity adsorbent.
- an affinity adsorbent is used as a medical adsorbent and an adsorbent for purifying a medical antibody, since an affinity adsorbent can efficiently purify a target substance and decrease a concentration of an unwanted substance.
- an adsorbent in which protein A is immobilized as an affinity ligand on a porous carrier is at the center of attention as an adsorbent for treating rheumatism, hemophilia and dilated cardiomyopathy (For example, Non-Patent Document 1, Non-Patent Document 2 and Non-Patent Document 3).
- an adsorbent in which protein A is immobilized on a porous carrier is also at the center of attention as an adsorbent on which an immunoglobulin, i.e. IgG, can be specifically adsorbed and which is used for purifying a medical antibody.
- a polysaccharide is widely used as a material of a medical porous carrier, since a polysaccharide can be industrially produced without difficulty and the safety thereof in a living body is exceedingly high.
- a porous cellulose carrier has excellent properties such as a relatively high mechanical strength, a number of hydroxy groups which can be utilized for binding ligands, a low non-specific adsorption and a higher safety in comparison with a synthetic polymer carrier (Patent Documents 1 and 2).
- Patent Document 3 discloses an adsorbent in which protein A is immobilized on a porous cellulose carrier.
- a porous cellulose carrier is generally produced by dissolving cellulose in a highly toxic solvent such as a calcium thiocyanate solution, since there are few solvents which can dissolve cellulose. Such a solvent is difficult to be handled in terms of corrosion and safety.
- an ionic liquid is recently at the center of attention, since an ionic liquid is non-volatile and a liquid condition can be kept over a wide temperature region.
- An ionic liquid is mainly applied as a functional solvent, a solvent for an ionic device and a solvent for dissolving a material derived from a living body, such as a polypeptide. It is recently found that an ionic liquid can dissolve cellulose; therefore, an ionic liquid is applied for producing a fiber (Patent Document 4).
- the objective of the present invention is to provide a method for easily producing a porous cellulose particle which can be used as an adsorbent for various substances in a safe manner without using a highly toxic solvent such as a calcium thiocyanate solution.
- the objective of the present invention is to provide a porous particle produced by the production method, an adsorbent which contains the porous particle and by which a highly pure protein can be efficiently purified in a safe manner, and a method for purifying a protein by using the adsorbent.
- an amorphous porous particle which has adequate size and an appropriate porosity as a material of a protein adsorbent can be efficiently produced in a safe manner by dissolving cellulose in an ionic liquid and contacting the obtained solution with a specific solvent, and completed the present invention.
- the step for preparing the cellulose solution in the present invention method it is preferred that water and/or an alcohol is added and an amount of the water and/or alcohol to be added is adjusted to be not less than 2 wt % and not more than 20 wt % relative to a total amount with the ionic liquid.
- a temperature of the cellulose solution it is preferred to adjust a temperature of the cellulose solution to be not less than 0° C. and not more than 70° C.
- a solubility of cellulose in an ionic liquid is high and it becomes easy to prepare the dispersion since a viscosity of the cellulose solution is low.
- the temperature is not more than 70° C., the solvent other than the ionic liquid is hardly volatilized when the cellulose solution and the dispersion are prepared.
- the dispersion is brought into contact with the alcohol or the alcohol aqueous solution under the condition of not less than 10° C.
- the temperature is preferably not less than 10° C.
- the porous particle according to the present invention is characterized in being produced by the above-described present invention method.
- the adsorbent according to the present invention is characterized in comprising an affinity ligand and the porous particle according to the present invention, wherein the affinity ligand is immobilized on the porous particle.
- a value of k is not more than ⁇ 0.1 under the condition that the following formula (I) holds when the porous particle or the adsorbent is packed in a column, gel phase distribution coefficients of multiple proteins having equal or higher molecular weight as compared to a target substance to be adsorbed are measured, and measured values are plotted with K av values on an abscissa and logarithm values of the molecular weights on an ordinate:
- K av represents the gel phase distribution coefficient
- MW represents the molecular weight of the protein
- b represents a constant
- the value of K av of the target substance to be adsorbed, specifically IgG, measured by using a column packed with the porous particle is not less than 0.3.
- the value of K av is not less than 0.3, an adsorption capacity becomes more excellent since a specific surface area relative to the molecular weight of the substance to be adsorbed becomes larger.
- an exclusion limit molecular weight is not less than 10 3 and not more than 10 9 .
- the exclusion limit molecular weight is included in the range, various useful proteins can be purified using the porous particle and the adsorbent according to the present invention.
- an amount of the affinity ligand to be introduced is not less than 1 mg and not more than 1000 mg per mL of the porous particle.
- the introduction amount is not less than 1 mL, the adsorbent may have a sufficient adsorption capacity more surely.
- the introduction amount is preferably not more than 1000 mg, since too much amount affinity ligand may not be possibly introduced onto the carrier and productivity may be possibly decreased in some cases.
- An amount of cellulose to be contained in the porous particle and the adsorbent according to the present invention is preferably not less than 2 wt % and not more than 50 wt %.
- the content is not less than 2 wt %, the adsorbent which is hardly compressed when purification is carried out in large scale at high velocity can be obtained.
- the content is not more than 50 wt %, sufficient pores through which a target substance to be purified can be passed can be ensured.
- the porous particle which is a carrier of the adsorbent according to the present invention, is cross-linked.
- the cross-linked porous particle can be used at high linear velocity and under high pressure, since such a particle has a high strength.
- a compressive stress when the porous particle or the adsorbent is compressed by 10% is not less than 0.01 MPa and not more than 3 MPa.
- the compressive stress is not less than 0.01 MPa, the particle and the adsorbent are hardly compressed even when a liquid is passed through at high linear velocity.
- the compressive stress is not more than 3 MPa, brittleness is improved and a microparticulate generation is inhibited more surely.
- a volume average particle diameter of the porous particle and the adsorbent according to the present invention is preferably not less than 1 ⁇ m and not more than 2000 ⁇ m.
- the volume average particle diameter is not less than 20 ⁇ m, the particle and the adsorbent are hardly compressed more surely.
- the volume average particle diameter is not more than 1000 ⁇ m, an amount of a target substance to be adsorbed may be increased.
- the affinity ligand of the adsorbent according to the present invention is preferably protein A.
- a cellulose porous particle can be produced more securely and at lower cost without using a calcium thiocyanate solution and the like, which are conventionally used.
- an ionic liquid used in the present invention method instead of a calcium thiocyanate solution, and a liquid which is not compatible with the ionic liquid can be separated from each other to be recovered after use. The recovered liquids can be reused. Therefore, the present invention method is also suitable for an industrial mass production.
- a cellulose porous particle which can be used as a carrier of an adsorbent for various substances can be provided by the present invention method.
- a viscosity of the dispersion obtained from the cellulose solution depends on the liquid which is not compatible with the ionic liquid. Therefore, an apparent viscosity of the cellulose solution having a high concentration can be kept down during handling; as a result, the operatability of the solution can be significantly improved.
- the cellulose porous particle produced by the present invention method is very useful as a carrier of an adsorbent for a protein and the like.
- FIG. 1 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Comparative Example 1.
- FIG. 2 is a photograph which was obtained by highly magnifying the FIG. 1 .
- FIG. 3 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Comparative Example 1.
- FIG. 4 is a photograph which was obtained by highly magnifying the FIG. 3 .
- FIG. 5 represents XRD patterns of the cellulose particles obtained in the Comparative Examples 1 to 3.
- FIG. 6 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 1.
- FIG. 7 is a photograph which was obtained by highly magnifying the FIG. 6 .
- FIG. 8 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 1.
- FIG. 9 is a photograph which was obtained by highly magnifying the FIG. 8 .
- FIG. 10 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 2.
- FIG. 11 is a photograph which was obtained by highly magnifying the FIG. 10 .
- FIG. 12 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 2.
- FIG. 13 is a photograph which was obtained by highly magnifying the FIG. 12 .
- FIG. 14 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 3.
- FIG. 15 is a photograph which was obtained by highly magnifying the FIG. 14 .
- FIG. 16 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 3.
- FIG. 17 is a photograph which was obtained by highly magnifying the FIG. 16 .
- FIG. 18 represents XRD patterns of the cellulose particles obtained in the Comparative Examples 1 and Examples 1 to 3.
- FIG. 19 represents XRD patterns of the cellulose particles obtained in the Examples 3 to 5.
- FIG. 20 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 7.
- FIG. 21 is a photograph which was obtained by highly magnifying the FIG. 20 .
- FIG. 22 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 8.
- FIG. 23 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 9.
- FIG. 24 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 10.
- FIG. 25 represents XRD patterns of the cellulose particles obtained in the Examples 8 to 10.
- a solution containing cellulose and an ionic liquid is prepared.
- An ionic liquid is generally an ionic compound in the form of a liquid at lower than 100° C. under ordinary pressure.
- a cationic part of an ionic liquid is exemplified by pyridinium, imidazolium, imidazole and the like.
- An acyclic cation is exemplified by a quaternary alkyl ammonium, a quaternary alkyl phosphonium cation and the like.
- a counter anion of a cationic part is selected from the group consisting of a halogen ion, a pseudo halogen ion, an organic halide ion which is an organic compound containing a halogen, a carboxylate and the like.
- a carboxylate is exemplified by an acetate, a citrate, a malate, a maleate, a formate and an oxylate;
- a halogen ion is exemplified by a chloride, a bromide, a zinc chloride/a choline chloride;
- an organic halide ion is exemplified by a tetrafluoroborate ion, a hexafluorophosphate ion, CF 3 SO 2 ⁇ , (CF 3 SO 2 ) 2 N ⁇ , CF 3 CO 2 ⁇ , 3-methyl-N-butyl-pyridinium chloride and benzyldimethyl (tetradecy) ammonium chloride.
- any cellulose which can be dissolved in an ionic liquid may be used in the present invention.
- one or more kinds of celluloses selected from a regenerated cellulose, a crystalline cellulose or a microcrystalline cellulose, and cellulose acetate may be used.
- a crystalline cellulose having an average polymerization degree of not less than about 100 and not more than about 700 is preferred.
- the average polymerization degree is not less than 100, the strength of the porous particles to be obtained can be made sufficient.
- the average polymerization degree may be too high, the viscosity of the cellulose solution can be excessively high and therefore, the average polymerization degree is preferably not more than 700.
- the average polymerization degree is more preferably not less than 100 and not more than 500, furthermore preferably not less than 150 and not more than 350, and particularly preferably not less than 200 and not more than 300.
- a crystalline cellulose having an average polymerization degree of about 300 is preferred.
- it is effective to add a poor solvent or to carry out operation at a high temperature for lowering the viscosity of the cellulose solution.
- An amount of cellulose to be used is not particularly limited and may be properly adjusted.
- such an amount is preferably not less than 2 wt % and not more than 50 wt % relative to 100 wt % of the cellulose solution.
- concentration is not less than 2 wt %
- an adsorbent which is not compacted even if purification is carried out at a high linear rate or in a large scale may be obtained.
- concentration is not more than 50 wt %, a sufficient pore through which a target substance to be purified can pass can be secured.
- the concentration is preferably not more than 50 wt %.
- the concentration is more preferably not less than 3 wt %, furthermore preferably not less than 4 wt %, particularly preferably not less than 5 wt %, and more preferably not more than 30 wt %, furthermore preferably not more than 20 wt %, particularly preferably not more than 15 wt %.
- a method for preparing the solution is not particularly limited and a common method may be employed.
- the solution may be prepared by simply mixing cellulose with an ionic liquid and heating or stirring the mixture until the cellulose is sufficiently dissolved.
- An inner structure of the porous particle can be controlled by adding one or more kinds selected from water and/or an alcohol to the solution containing cellulose and an ionic liquid to an extent that cellulose is not precipitated. More specifically, a pore diameter of the porous particle can be made more uniform by adding a poor solvent for cellulose to the solution.
- an alcohol concentration may be properly adjusted; and for example, a ratio of water:an alcohol may be set as [80:20] to [5:95] by volume.
- An amount of water and/or an alcohol to be added may be properly adjusted to an extent that cellulose is not precipitated at ordinary temperature and for example, the amount may be adjusted to be not less than 2 wt % and not more than 20 wt % relative to the total amount of an ionic liquid and water and/or an alcohol to be added.
- the additive amount is not less than 2 wt %, an effect to make a pore diameter of the porous particle uniform is more reliably exerted.
- the additive amount is preferably not more than 20 wt %, and more preferably not more than 15 wt %.
- the mixture may be heated.
- a common ionic liquid is in a form of a liquid at lower than 100° C.
- the temperature is more preferably not less than 50° C. and not more than 90° C.
- cellulose may be previously microparticulated.
- the obtained cellulose solution is dispersed in a liquid which is not compatible with the ionic liquid to prepare a dispersion.
- a temperature of the above-described cellulose solution is preferably adjusted to be not less than 0° C. and not more than 70° C. before or during dispersion in a liquid which is not compatible with the ionic liquid.
- a solubility of cellulose in the ionic liquid is high, and the viscosity of the cellulose solution is lowered so as to make the preparation of the dispersion easy.
- the temperature is not more than 70° C., a solvent other than the ionic liquid is hardly evaporated at the time of preparation of the cellulose solution or the dispersion.
- a liquid which is not compatible with an ionic liquid is needed for dissolving 1 g or 1 mL of the employed ionic liquid at 25° C.
- a liquid may be selected depending on the kind of an ionic liquid to be used, and is exemplified by hexane, ethyl acetate, a C 6-12 linear saturated fatty acid, a C 16-24 unsaturated fatty acid, a fat and oil which is derived from an animal or a plant and of which melting point is not more than 100° C., a hydrogenated oil derived from an animal or a plant, a fractionated oil obtained by fractionizing and purifying a high melting point fraction of a fat and oil derived from an animal or a plant or a hydrogenated product thereof, a saturated fatty acid triglyceride, an edible wax, a microalgae-derived fat and oil, a microorganism fat and oil, a medium chain fatty acid trigly
- the fat and oil to be used for the present invention is not particularly limited as long as the fat and oil has a melting point of not more than 100° C.
- the fat and oil is exemplified by a fat and oil derived from an animal or a plant, such as a palm oil, a shea butter, a sal butter, an illipe butter, a lard, a tallow, a rapeseed oil, a rice oil, a peanut oil, an olive oil, a corn oil, a soybean oil, a perilla oil, a cotton seed oil, a sunflower oil, an evening primrose oil, a sesame oil, a safflower oil, a coconut oil, a cocoa butter, a palm kernel oil and a fish oil; a hydrogenated animal or plant oil such as a hydrogenated palm oil, an extremely hydrogenated palm oil, a hydrogenated rapeseed oil, an extremely hydrogenated rapeseed oil, a hydrogenated soybean oil, a hydrogenated lard
- Only one kind of the above-described liquid which is not compatible with an ionic liquid may be used alone, or two or more kinds may be used in the form of a mixture.
- the examples of the case of mixing two or more kinds may include a mixed solvent of saturated fatty acids with different numbers of carbon atoms, a mixed solvent of unsaturated fatty acids with different numbers of carbon atoms, and a mixed solvent of a saturated fatty acid and an unsaturated fatty acid.
- a surfactant may be used for dispersing an ionic liquid in a liquid which is not compatible with the ionic liquid.
- a surfactant is exemplified by N-acyl-L-glutamic acid triethanolamine, sodium N-acyl-L-glutamate, an alkyldiaminoethylglycine hydrochloride liquid, dimethicone copolyol, polyoxyethylene octyl phenyl ether, polyoxyethylene stearyl ether, polyoxyethylene cetyl ether, polyoxyethylene-polyoxypropylene glycol, glyceryl monostearate, propylene glycol monostearate, polyoxyethylene glyceryl monostearate, polyoxyethylene sorbitan monostearate, polyethylene glycol monophosphate and the like. From the viewpoints of coloration suppression on cellulose, solution viscosity and the like, a medium chain fatty acid triglyceride is preferred as a surfactant.
- Droplets of the cellulose solution are formed by dispersing the cellulose solution in the above-described liquid.
- the use amounts of the cellulose solution and a liquid which is not compatible with the ionic liquid are not particularly limited and may be properly adjusted, and a ratio of the liquid:the cellulose solution may be adjusted to be [98:2] to [50:50] by volume.
- the volume ratio is preferably [97:3] to [70:30], and more preferably [97:3] to [80:20].
- a method for dispersing the cellulose solution is not particularly limited, and for example, the cellulose solution can be homogeneously dispersed in a liquid which is not compatible with the ionic liquid by stirring using a stirring blade or a homogenizer.
- a static mixer can also be employed.
- the above-mentioned dispersion is solidified by bringing into contact with an alcohol or an alcohol aqueous solution to obtain porous particles.
- an ionic liquid in the droplets is extracted to insolubilize and condense cellulose and thus porous particles consisting of cellulose can be obtained.
- An alcohol to be employed in the present step is exemplified by a C 1-6 alcohol such as methanol, ethanol, 1-propanol, 2-propanol, n-butanol, isobutanol, 2-butanol, sec-butanol, 2-methyl-2-propanol (tert-butanol), 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butanol, 3-methyl-1-butanol, 2-methyl-2-butanol, 3-methyl-2-butanol, 1-hexanol, 2-hexanol, 3-hexanol and the like.
- a C 1-6 alcohol such as methanol, ethanol, 1-propanol, 2-propanol, n-butanol, isobutanol, 2-butanol, sec-butanol, 2-methyl-2-propanol (tert-butanol), 1-pentanol, 2-pentan
- a concentration of an alcohol aqueous solution is not also particularly limited and may be properly adjusted, and for example, a ratio of water:an alcohol may be adjusted to be [80:20] to [5:95] by volume.
- a ratio of water:an alcohol may be adjusted to be [80:20] to [5:95] by volume.
- the inventors of the present invention found that fine pores of the porous particle become larger as the volume ratio of water in the alcohol aqueous solution is higher, and that the sphericity of the porous particles becomes higher and the porous particles become more amorphous as the volume ratio of alcohol is higher.
- the volume ratio is more preferably [70:30] to [10:90], furthermore preferably [50:50] to [10:90], and particularly preferably [40:60] to [20:80].
- a method for bringing the above-described dispersion into contact with an alcohol or an alcohol aqueous solution is not particularly limited, and the entire amount of the alcohol or the alcohol aqueous solution may be added to the dispersion, a portion of the alcohol or the alcohol aqueous solution may be added step by step to the dispersion, the entire amount of the dispersion may be added to the alcohol or the alcohol aqueous solution, or a portion of the dispersion may be added step by step to the alcohol or the alcohol aqueous solution.
- the dispersion is gradually added to a stirred alcohol or alcohol aqueous solution.
- An amount of an alcohol or an alcohol aqueous solution to be used is not particularly limited and may be a sufficient amount to extract the ionic liquid, and for example, the volume ratio of the alcohol or alcohol aqueous solution relative to the dispersion may be adjusted to be not less than 1 and not more than 5.
- a temperature at the time of the contact is not also particularly limited and is preferably adjusted to be not less than the melting point of the ionic liquid and not more than the boiling point of an alcohol to be used.
- the temperature is preferably not less than 10° C. and not more than 60° C., more preferably not less than 25° C. and not more than 60° C., and particularly preferably not less than 40° C. and not more than 55° C.
- a porosity of the solidified cellulose particle is surprisingly affected by the temperature of the cellulose solution and either the alcohol or the alcohol aqueous solution, and a fine pore diameter of the cellulose particle becomes larger as the solution temperature is higher. Also in the point, the temperature is preferably adjusted within the above-described preferred range.
- the maximum diameter thereof is preferably not less than 200 angstroms and not more than 1500 angstroms, and the average diameter thereof is preferably not less than 100 angstroms and not more than 400 angstroms.
- the average diameter is more preferably not less than 140 angstroms and not more than 400 angstroms, and furthermore preferably not less than 200 angstroms and not more than 400 angstroms.
- the cellulose particle obtained in the above-described manner is porous, and the size of the pore and the hardness thereof can be controlled by changing a cellulose concentration, a dispersion temperature, and a cellulose-insoluble liquid.
- a means for recovery is not particularly limited, and a common solid-liquid separation means such as filtration and centrifugation may be employed.
- the obtained porous particle may be washed with water or an alcohol and thereafter dried in reduced pressure in order to remove the ionic liquid and the cellulose-insoluble liquid remaining in the pores if necessary.
- the used ionic liquid can be recovered by evaporating the cellulose-insoluble liquid from the obtained liquid by solid-liquid separation.
- the porous particle obtained by the above-described method of the present invention can be further improved in strength by a crosslinking agent.
- a crosslinking agent and crosslinking reaction condition are not particularly limited, and known techniques can be employed.
- the crosslinking agent is exemplified by a halohydrine such as epichlorohydrin, epibromohydrin and dichlorohydrin; a bifunctional bisepoxide (bisoxirane); and a polyfunctional polyepoxide (polyoxirane).
- the size of the porous particle is not particularly limited, and in general, is preferably not less than about 1 ⁇ m and not more than about 2 mm.
- a volume average particle diameter is preferably not less than 20 ⁇ m and not more than 1000 ⁇ m.
- the volume average particle diameter of the porous particle is not less than 20 ⁇ m, compaction is difficult to be caused.
- the volume average particle diameter is not more than 1000 ⁇ m, an adsorption amount of a target substance to be purified is increased in the case where the porous particles are used for an adsorbent carrier for purification.
- the volume average particle diameter of the porous particle is more preferably not less than 20 ⁇ m, furthermore preferably not less than 30 ⁇ m, particularly preferably not less than 50 ⁇ m, most preferably not less than 60 ⁇ m, and more preferably not more than 500 ⁇ m, furthermore preferably not more than 250 ⁇ m, particularly preferably not more than 125 ⁇ m, most preferably not more than 95 ⁇ m.
- the volume average particle diameter can be determined by measuring the particle diameter of randomly selected 100 porous particles.
- the particle diameter of each porous particle can be measured by photographing a microscopic photograph of each porous particle, saving the photograph in the form of electronic data, and carrying out an analysis using a particle diameter measurement software such as Image-Pro Plus manufactured by Media Cybernetics, Inc.
- the measurement can also be carried out by using a laser diffraction/scattering particle size distribution measuring device.
- the size of the porous particle can be controlled by the stirring intensity, the kind of a surfactant or the like at the time of the dispersion or at the time of bringing the dispersion into contact with an alcohol or an alcohol aqueous solution.
- the cellulose porous particle obtained in the above-described manner is used as a carrier.
- an affinity ligand which has high affinity to a target substance to be adsorbed is immobilized on the above-described porous cellulose particle.
- An affinity ligand means a molecule or a compound which is interacted with a specific target substance and is capable of having a specific affinity to the specific target substance.
- an affinity ligand is exemplified by an antigen and a protein which cause specific interaction, a peptide having antibody bonding activity, and the like.
- An affinity ligand to be used for the adsorbent of the present invention is not particularly limited, and various affinity ligands can be immobilized by using a porous carrier which is activated for immobilizing a desired affinity ligand.
- a method of immobilization is exemplified by a method for immobilizing an amino group-containing ligand by employing a cyanogen bromide method, a trichlorotriazine method, an epoxy method, a tresyl chloride method, a periodate oxidation method, a divinylsulfonic acid method, a benzoquinone method, a carbonyl diimidazole method, an acyl azide method and the like; a method for immobilizing a hydroxy group-containing ligand by employing an epoxy method, a diazo coupling method and the like; a method for immobilizing a thiol group-containing ligand by employing an epoxy method, a tresyl chloride method
- the adsorbent of the present invention can be used as an adsorbent for purification and can also be used as an adsorbent for purifying an antibody pharmaceutical product, which has drawn attention in recent years.
- An affinity ligand to be used for purifying an antibody pharmaceutical product is not particularly limited, and is exemplified by an antigen and a protein which have high specificity to an antibody, protein G, protein L, a variant thereof, and an amino group-containing ligand such as a peptide having an antibody bonding activity.
- an adsorbent which can specifically adsorb and elute an immunoglobulin (particularly, IgG)
- an adsorbent obtained by immobilizing protein A as an affinity ligand on a porous carrier is drawing attention.
- the protein A to be used for the present invention is not particularly limited, and a natural protein A, a gene recombinant protein A and the like can be used without limitation.
- protein A may include an antibody bonding domain and a variant thereof, and may be a fusion protein and the like.
- protein A which is produced from a microbe extract or a culture supernatant by combining and/or repeating purification methods selected from a molecular weight fraction method and fractional precipitation method which employs various kinds of chromatography such as ion exchange chromatography, hydrophobic interaction chromatography, gel filtration chromatography and hydroxyapatite chromatography, and a membrane separation technique.
- protein A obtained by the method disclosed in WO 2006/004067, U.S. Pat. No. 5,151,350 B, WO 2003/080655, JP 2006-304633 A or Japanese Patent Application No. 2009-071766 is preferred.
- a method for introducing protein A as an affinity ligand into the porous particle can be selected from the various immobilization methods as described above, and a method of immobilization by utilizing the reaction of a formyl group which is possessed by the porous particle and the amino group of protein A is more preferred.
- a method described in Patent Document 1 can be used.
- An amount of an affinity ligand to be introduced into the adsorbent of the present invention is not particularly limited, and for example, may be adjusted to be not less than 1 mg and not more than 1000 mg per 1 mL of the porous carrier.
- the ratio is not less than 1 mg, the adsorption amount for a target substance to be purified may be preferably increased.
- the ratio is not more than 1000 mg, a production cost may be preferably suppressed.
- the amount of the affinity ligand to be introduced is more preferably not less than 2 mg, furthermore preferably not less than 4 mg, particularly preferably not less than 5 mg, and more preferably not more than 500 mg, furthermore preferably not more than 250 mg, particularly preferably not more than 200 mg, most preferably not more than 100 mg per 1 mL of the porous carrier.
- porous particle in the case where the porous particle is used as a porous carrier for the adsorbent is described.
- a fine pore diameter thereof is one of important factors. For example, when a fine pore diameter is smaller than a target substance to be adsorbed, adsorption is caused only on the surface of the adsorbent carrier and an adsorption amount may possibly become low. On the other hand, when a fine pore diameter is too large, a specific surface area becomes small and an adsorption amount may possibly become low. Accordingly, the porous carrier which has a proper fine pore diameter for a target substance to be adsorbed is preferred.
- K av means a gel phase distribution coefficient, and is a variable number which is independent from a column and which is calculated in accordance with the following formula from an elution or retention volume V R (expressed also as V e ) for molecules in a prescribed size, a void volume V o and a geometrical volume V c of a column.
- K av ( V R ⁇ V o )/( V t ⁇ V o )
- K av value but not an accurate value of a fine pore diameter is because it is difficult to accurately measure the fine pore diameter when the porous particles are dispersed in a solvent and made into a wet state like a gel for column chromatography, and an estimated fine pore diameter measured in a dry state cannot accurately reflect a fine pore diameter in a wet state.
- An adsorption amount can be improved by immobilizing an affinity ligand on the porous carrier which shows a straight line with an inclination of not more than ⁇ 0.1 in a range of molecular weight of equal to or more than the molecular weight of a target substance to be adsorbed when K av values are plotted on the abscissa and the logarithm values of the molecular weights are plotted on the ordinate.
- an adsorbent obtained by immobilizing an affinity ligand on the porous carrier of which value of k is not more than ⁇ 0.1 (k ⁇ 0.1 or k ⁇ 0.1) under the condition that the following formula (I) holds in a molecular weight region of equal to or more than the molecular weight of a target substance to be adsorbed.
- k represents an inclination
- MW represents a molecular weight of a marker when K av is measured
- b represents a constant
- a value of k is preferably not more than ⁇ 0.15, more preferably not more than ⁇ 0.20, furthermore preferably not more than ⁇ 0.30, and particularly preferably not less than ⁇ 5.0 and not more than ⁇ 0.35.
- a value of K av for a molecular weight of a target substance to be adsorbed is not less than 0.3.
- a value of K av for a molecular weight of a target substance to be adsorbed is not less than 0.3, a specific surface area for the molecular weight of the substance to be adsorbed becomes larger, and efficient adsorption is made possible.
- a value of K av is more preferably not less than 0.55, furthermore preferably not less than 0.65, and particularly preferably not less than 0.75.
- a value of K av is preferably not more than 0.94. When a value of K av is more than 0.94, a resin content is lowered and a strength of the adsorbent may possibly be lowered.
- an exclusion limit molecular weight of the porous carrier is higher than a molecular weight of a target substance to be adsorbed.
- a target substance to be adsorbed is often a protein and generally, a molecular weight of a protein is not less than about 10 3 and not more than about 10 8 and therefore, it is preferred that an exclusion limit molecular weight is set to be not less than about 10 3 and not more than about 10 9 .
- an exclusion limit molecular weight is set to be not less than about 10 6 and not more than about 10 8 .
- an exclusion limit molecular weight can be determined by employing a conventionally known method.
- an exclusion limit molecular weight is a molecular weight when K av is 0, and therefore can be determined according to the following formula (II) obtained by substituting 0 for K av in the above-described formula (I).
- a marker compound to be used for the measurement is preferably a compound which is analogous with a target substance to be adsorbed.
- a synthetic polymer such as polystyrene
- a protein even if the molecular weights thereof are same, the volumes thereof are different in a measurement solution.
- a target substance to be adsorbed is an antibody
- a porous particle which has high cellulose content can be produced, since a cellulose solution with high concentration can be prepared by using an ionic liquid. Such a porous particle cannot be obtained by a conventional method.
- resin content is high
- an adsorbent which does not cause compaction can be obtained.
- Cellulose content per packing volume of the present invention adsorbent is not particularly limited, and is preferably not less than 2 wt % and not more than 50 wt %. When cellulose content per packing volume is not less than 2 wt %, it is possible to preferably obtain an adsorbent which does not cause compaction even if purification is carried out at a high linear rate or in a large scale.
- cellulose content per pecking volume is not more than 50 wt %, sufficient pores which are preferably capable of passing a target substance to be purified can be secured.
- a cellulose content per packing volume is more preferably not less than 3 wt %, furthermore preferably not less than 4 wt %, and more preferably not more than 25 wt %, furthermore preferably not more than 15 wt %.
- Cellulose content per packing volume can be determined according to the following formula (III) as follows. That is, the porous particles are packed by precipitation until a volume of the porous particles is not further decreased, and a porous particle amount is adjusted so that the porous particle volume is 1 mL. The particles are dried at 105° C. for 12 hours, and the dry weight percent per 1 mL of gel, that is, the cellulose content, can be determined from a dry weight (g) per packing volume.
- a compressive stress when the adsorbent of the present invention is compressed by 5% is not less than 0.005 MPa and not more than 1 MPa
- a compressive stress when the adsorbent is compressed by 10% is not less than 0.01 MPa and not more than 3 MPa
- a compressive stress when the adsorbent is compressed by 15% is not less than 0.03 MPa and not more than 5 MPa.
- a compressive stress when the adsorbent is compressed by 5% is not less than 0.005 MPa and a compressive stress when compressed by 10% is not less than 0.01 MPa and a compressive stress when compressed by 15% is not less than 0.03 MPa, it is easy to obtain an adsorbent which does not cause compaction even if a liquid is introduced at a high linear rate. If a compressive stress when the adsorbent is compressed by 5% is not more than 1 MPa and a compressive stress when compressed by 10% is not more than 3 MPa and a compressive stress when compressed by 15% is not more than 5 MPa, a brittleness is preferably improved and fine particle generation can be preferably suppressed.
- a compressive stress when compressed by 5% means a stress at the time of 5% decrease in volume from the initial volume when the adsorbent is compressed;
- a compressive stress when compressed by 10% means a stress at the time of 10% decrease in volume from the initial volume when the adsorbent is compressed;
- a compressive stress when compressed by 15% means a stress at the time of 15% decrease in volume from the initial volume when the adsorbent is compressed.
- the initial volume is a volume in a state where the adsorbent is deposited to be packed until a volume of the adsorbent is not further decreased while applying vibration to a slurry containing the adsorbent.
- a compressive stress when the adsorbent is compressed can be measured by the following method.
- the adsorbent is added with water in an amount to allow the entire volume to be 2 times to produce a slurry, and the slurry is loaded into a graduated cylinder made of glass having an inner diameter of 15 mm. 2) The adsorbent is deposited to be packed until a volume of the adsorbent is not further decreased by applying vibration to the graduated cylinder made of glass, and an amount of the adsorbent is adjusted so that a volume of the adsorbent is about 4 mL. The volume at the time is defined as the initial volume.
- a piston made of a metal which does not cause friction with the inner wall of the graduated cylinder and which is processed to prevent elution of the adsorbent is attached to an autograph (EZ-TEST, manufactured by SHIMADZU CORPORATION) equipped with a load cell for 20N. 4) The position of the piston is adjusted so that the bottom surface of the piston is moved to the position corresponding to 120 vol % of the adsorbent. 5) The piston is lowered at a testing rate of 5 mm/min in a manner of preventing entrainment of bubbles, and the porous carrier is compressed and the volume is decreased. 6) The compressive stress at a prescribed point is measured.
- the adsorbent obtained by immobilizing an affinity ligand on the porous carrier having the above-described physical properties is expected to efficiently adsorb a target substance to be adsorbed at a high linear rate and in a large scale.
- the adsorbent of the present invention is preferably has an adsorption amount of a target substance to be adsorbed of not less than 1 mg per 1 mL of the adsorbent.
- an adsorbed target substance can be easily eluted from the adsorbent.
- the adsorption amount of a target substance to be adsorbed by the adsorbent is more preferably not less than 5 mg, furthermore preferably not less than 10 mg, particularly preferably not less than 20 mg, most preferably not less than 30 mg, and preferably not more than 500 mg, furthermore preferably not more than 300 mg, particularly preferably not more than 250 mg, most preferably not more than 200 mg per 1 mL of the adsorbent.
- An amount of a target substance to be adsorbed can be determined as follows.
- a method for determining an adsorption amount of a target substance is not particularly limited, and an adsorption amount can be determined as a static adsorption amount or as a dynamic adsorption amount.
- a static adsorption amount can be determined by bringing a solution obtained by dissolving 70 mg of a target substance to be adsorbed in 35 mL of a phosphate buffer (produced by Sigma) having a pH of 7.4 into contact with 0.5 mL of an adsorbent of which solvent is substituted with a phosphate buffer (produced by Sigma) having a pH of 7.4, stirring the mixture at 25° C. for 2 hours, and then measuring a decreased amount of the target substance to be adsorbed in a supernatant.
- a phosphate buffer produced by Sigma
- a solution a phosphate buffer which has a pH of 7.4 (produced by Sigma); B solution: 35 mM sodium acetate which has a pH of 3.5 (prepared from acetic acid and sodium acetate produced by Wako Pure Chemical Industries, Ltd. and RO water); C solution: 1 M acetic acid (prepared from acetic acid produced by Wako Pure Chemical Industries, Ltd.
- D solution a 1 mg/mL human polyclonal IgG solution (prepared from Gammagard produced by Baxter and the A solution); E solution: 6 M urea; F solution: a liquid obtained by adding 0.2 vol % of a surfactant (polyoxyethylene (20) sorbitan monolaurate, produced by Wako Pure Chemical Industries, Ltd.) to the A solution; Neutralizing solution: 2M tris(hydroxymethyl)aminomethane (prepared from tris(hydroxymethyl)aminomethane produced by Sigma and RO water).
- a surfactant polyoxyethylene (20) sorbitan monolaurate, produced by Wako Pure Chemical Industries, Ltd.
- AKTA explorer 100 manufactured by GE Healthcare Bioscience
- a mesh of 22 ⁇ m is attached to a column having a diameter of 0.5 cm and a height of 15 cm.
- 3 mL of each adsorbent of the present invention is loaded and packed by passing a 20% ethanol aqueous solution (prepared from ethanol produced by Wako Pure Chemical Industries, Ltd. and RO water) at a linear rate of 400 cm/hr for 1 hour.
- Sampling tubes having a volume of 15 mL are set to a fraction collector, and sampling tubes for an effluent are previously filled with the neutralizing solution.
- the respective solutions in an amount of 3 times as much as that of the adsorbent are allowed to pass at a linear rate of 300 cm/hr in the order of the F solution, the B solution, the A solution, the C solution and the E solution.
- the solution passing cycle is repeated an arbitrary number of times.
- the A solution in an amount of 9 mL is allowed to pass at a linear rate of 300 cm/hr and subsequently, while monitoring UV, the D solution is allowed to pass at a linear rate of 300 cm/hr until 10% of IgG is eluted.
- 30 mL of the A solution is allowed to pass at a linear rate of 300 cm/hr and 30 mL of the B solution is allowed to pass at a linear rate of 300 cm/hr to elute IgG.
- 9 mL of the C solution is allowed to pass at linear rate of 300 cm/hr and 9 mL of the E solution is allowed to pass at linear rate of 300 cm/hr.
- the operation after completion of the packing of the adsorbent is repeated further 2 times to measure the IgG amount in the effluent and the concentration of the ligand which leaks in IgG.
- the adsorbent of the present invention can be used for purifying various kinds of target substances such as a protein by employing affinity chromatography, for various kinds of purification method as disclosed in Non-Patent Document 3, and for an adsorbent of therapy and an adsorbent for medical treatment.
- a purification method or a therapeutic method is not particularly limited, and the methods disclosed in Non-Patent Documents 1, 2 and 3 and other known methods can be preferably applied.
- a column having a diameter of not less than 0.5 cm and a height of not less than 3 cm is used.
- a size of the column is preferably not more than 2000 cm in diameter and not more than 5000 cm in height.
- a size of a column is more preferably not less than 2 cm and not more than 400 cm in diameter and not less than 5 cm and not more than 400 cm in height, furthermore preferably not less than 5 cm and not more than 300 cm in diameter and not less than 8 cm and not more than 200 cm in height, particularly preferably not less than 10 cm and not more than 250 cm in diameter and not less than 12 cm and not more than 100 cm in height, and most preferably not less than 20 cm and not more than 150 cm in diameter and not less than 15 cm and not more than 50 cm in height.
- Therapy or purification in which the adsorbent of the present invention is used preferably comprises the step of allowing a liquid to pass at a linear rate of not less than 10 cm/hr.
- therapy or purification can be carried out efficiently.
- therapy or purification using the adsorbent of the present invention is preferably carried out at a linear rate of not more than 5000 cm/hr.
- the linear rate for purification is more preferably not less than 50 cm/hr, furthermore preferably not less than 100 cm/hr, particularly preferably not less than 200 cm/hr, most preferably not less than 300 cm/hr, and more preferably not more than 3000 cm/hr, furthermore preferably not more than 1500 cm/hr, particularly preferably not more than 1000 cm/hr, most preferably not more than 750 cm/hr.
- a tapped volume is used for representing a volume of the porous particle which was used for a reaction when the adsorbent according to the present invention was produced, unless otherwise specified.
- a tapped volume is a volume of the porous particle under the condition that a slurry of the porous particle and RO water is added into a measuring container and the porous particles are deposited until the volume is not decreased any more while applying vibration.
- a volume of the porous particle as a base of a ratio of a functional group is also a tapped volume unless otherwise specified. In the case where the porous particle was deficient in respective tests, the porous particle was produced in the same manner to be added.
- Porous particles (4 mL) of which solvent was substituted with a 0.1 M phosphate buffer having a pH of 8 were brought into contact with 2 mL of a 0.1 M phosphate buffer solution having a pH of 8 in which phenylhydrazine was dissolved, and the mixture was stirred at 40° C. for 1 hour.
- the maximum absorbance of the supernatant of the reaction mixture around 278 nm was measured by UV absorbance measurement. From the measurement result, the formyl group content was estimated as the adsorption amount of phenylhydrazine to the porous particles.
- the loading amount of phenylhydrazine was adjusted to be 3 times by mole as much as that of the expected formyl group content.
- the loading amount of phenylhydrazine was reexamined and the measurement was to be carried out again.
- Porous particles were dispersed in RO water and degassed for 1 hour.
- the degassed porous particles were packed in a column (Tricorn 10/300, manufactured by GE Healthcare Japan) at a linear rate of 105 cm/hr. Thereafter, an eluent (129 mL) having a pH of 7.5 was allowed to pass through the column at a linear rate of 26 cm/hr.
- Thyroglobulin manufactured by Sigma, MW 660,000
- Aldolase manufactured by Sigma, MW 158,000
- Bovine Serum Albumin manufactured by Wako
- Cytochrome C (manufactured by Wako), MW 12,400
- the above-described markers were diluted with a buffer having a pH of 7.5 so that the concentrations were adjusted to be 5 mg/mL. While the above-described eluent was allowed to pass through the column at a linear rate of 26 cm/hr, each 12 ⁇ L of the diluted solutions were injected. The concentration of each marker was finely adjusted as necessary.
- DGU-20A3, SCL-10A, SPD-10A, LC-10AD, SIL-20AC, CTO-10AC (all of which were manufactured by SHIMADZU CORPORATION) were used, and LC Solution was used as measurement software.
- LC Solution was used as measurement software.
- a 50 mL-graduated cylinder was used for a liquid volume measurement.
- a liquid volume corresponding to the first peak for Blue Dextran was defined as V 0 (mL).
- a gel phase distribution coefficient (K av ) of each marker was calculated according to the following formula.
- K av ( V R ⁇ V o )/( V t ⁇ V o )
- the molecular weight when a value of K av is 0, that is, an exclusion limit molecular weight was determined.
- the following correlation equation of a diameter and a molecular weight of a spherical protein in a neutral buffer was substituted with the exclusion limit molecular weight, and the calculated value was defined as the maximum diameter of the pores of sample particles.
- Diameter of spherical protein in neutral buffer solution(angstrom) 2.523 ⁇ (molecular weight) 0.3267
- a value of K av of the adsorbent for a target substance to be adsorbed was determined by measuring values of K av of two or more kinds of proteins having molecular weights close to that of a target substance to be adsorbed and carrying out calculation from the obtained data. For example, when a target substance to be adsorbed was IgG, a value of K av was determined from data of ferritin and albumin.
- a median diameter was measured by using a laser diffraction/scattering particle size distribution analyzer (LA-950, manufactured by Horiba Ltd.). The measured value was defined as an average particle diameter.
- a static binding capacity was determined by the following procedures:
- a solution was obtained by dissolving 70 mg of human polyclonal IgG (0.467 mL of 1500 mg/10 mL Gamma-Globulin NICHIYAKU, produced by Nichiyaku) in a phosphate buffer (produced by Sigma) having a pH of 7.4 and adjusting the entire amount to be 35 mL;
- a solution a phosphate buffer having a pH of 7.4 (produced by Sigma)
- B solution 35 mM sodium acetate having a pH of 3.5 (prepared from acetic acid and sodium acetate produced by Nacalai Tesque, Inc. and RO water)
- C solution 1 M acetic acid (prepared from acetic acid produced by Nacalai Tesque, Inc. and RO water)
- D solution 1 mg/mL human polyclonal IgG solution (prepared from 1500 mg/10 mL Gamma-Globulin NICHIYAKU, produced by Nichiyaku and the A solution)
- E solution 6M urea (prepared from urea produced by KANTO CHEMICAL CO., INC. and RO water)
- AKTA explorer 100 manufactured by GE Healthcare Bioscience
- a mesh of 22 ⁇ m was attached to a column having a diameter of 0.5 cm and a height of 15 cm.
- 3 mL of each adsorbent of the present invention was loaded and packed by passing a 20% ethanol aqueous solution (prepared from ethanol produced by Wako Pure Chemical Industries, Ltd. and RO water) at a linear rate of 450 cm/hr for 1 hour.
- Sampling tubes having a volume of 15 mL were set to a fraction collector, and sampling tubes for an effluent were previously filled with the neutralizing solution.
- the A solution in an amount of 9 mL was allowed to pass at a linear rate of 300 cm/hr and subsequently, while monitoring UV, the D solution was allowed to pass at a linear rate of 300 cm/hr until 10% of IgG was eluted.
- 30 mL of the A solution was allowed to pass at a linear rate of 300 cm/hr and 30 mL of the B solution was allowed to pass at a linear rate of 300 cm/hr to elute IgG.
- 9 mL of the C solution was allowed to pass at linear rate of 300 cm/hr and 9 mL of the E solution was allowed to pass at linear rate of 300 cm/hr.
- a slurry containing 50 vol % of the porous particle or the adsorbent was loaded to a graduated cylinder which was made of glass and which had an inner diameter of 15 mm.
- the porous particle or adsorbent was deposited to be packed until the volume of the porous particle or adsorbent was not further decreased by applying vibration to the graduated cylinder made of glass, and the amount of the porous particle or adsorbent was adjusted as to set the volume of the porous particle or adsorbent to be 4 mL.
- the volume at the time was defined as the initial volume.
- a piston made of a metal (which did not cause friction with the inner wall of the graduated cylinder and was processed to prevent elution of the porous particle or adsorbent) was attached to an autograph (EZ-TEST, manufactured by SHIMADZU CORPORATION) equipped with a load cell for 20N.
- the position of the piston was adjusted so that the bottom surface of the piston was moved to the position corresponding to 120 vol % of the porous particle or adsorbent.
- the piston was lowered at a testing rate of 5 mm/min in a manner of preventing entrainment of bubbles, and the porous particle or adsorbent was compressed and the volume was decreased.
- the compressive stress at arbitrary positions was measured.
- Crystalline cellulose (2.73 g) was dissolved in 1-ethyl-3-methylimidazolium acetate (produced by Sigma Aldrich, 20 g) at 70° C. to prepare a 12.0 wt % solution. From the cellulose solution, an amount of 15 mL was measured to be taken out. The measured amount of the solution was added to medium chain fatty acid triglyceride (MCT) (Acta M-2, fatty acid composition: 100% of C8, 85 mL, produced by Riken Vitamin Co., Ltd.) that was stirred at a rate of 4000 rpm by a homogenizer (HG-200, manufactured by HSIANGTAI). The cellulose solution was dispersed in MCT by stirring for 5 minutes.
- MCT medium chain fatty acid triglyceride
- the dispersion was gradually added to water at 25° C. that was stirred at a rate of 300 rpm to solidify the cellulose.
- the dispersion was settled to separate a liquid phase.
- a bilayer solution composed of an upper layer containing MCT and a lower layer containing water and 1-ethyl-3-methylimidazolium acetate was observed.
- the cellulose was deposited in the lower layer.
- the cellulose was recovered and washed with methanol and thereafter washed with water. It was found by observation with a microscope (Digital Microscope VH-6200, manufactured by Keyence Corporation) that particulate cellulose was obtained.
- the microscopic image of the obtained particles was analyzed by using a commercially available image analyzing processing software (Motic Images Plus, manufactured by Motic) to measure an average aspect ratio.
- the average aspect ratio was determined by calculating the aspect ratio of each particle from the measured major axis and minor axis of the particles in the image and calculating the average of the calculated ratios.
- a median diameter was measured by using a laser diffraction/scattering particle size distribution analyzer (LA-950, manufactured by Horiba Ltd.) and employed the measured value as an average particle diameter. As a result, it was proved that fine cellulose particles with complete sphericity and having an average particle diameter of 104.0 ⁇ m and an average aspect ratio of 1.10 were obtained.
- the hardness of the cellulose particle was evaluated by measuring the compressive strength with the use of a compressive strength testing apparatus (EZ-TEST, manufactured by SHIMADZU CORPORATION). As a result, when the volume was compressed by 10%, the stress was 0.042 Mpa and it was apparent that the cellulose particle had proper hardness.
- the inside of the pores of the obtained cellulose particles was replaced with 2-methyl-2-propanol, and the obtained cellulose particles were dried by freeze drying and then analyzed with a scanning electron microscope (S-800, manufactured by Hitachi Ltd., hereinafter referred to as “SEM”). As a result, the cellulose particles were confirmed to be porous particles as shown in FIGS. 1 to 4 .
- the dried cellulose particles were analyzed by powder x-ray diffraction (XRD, Rigaku Mini Flex II, the same applies hereinafter). The results are shown in FIG. 5 . As shown in FIG. 5 , it was confirmed that the cellulose particles were crystalline.
- Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 10.0 wt %. As a result, cellulose particles having an average particle diameter of 121.4 ⁇ m and an average aspect ratio of 1.12 were obtained. When the cellulose volume was compressed by 10%, the stress was 0.015 Mpa. The obtained particles were porous particles similar to those of the Comparative Example 1.
- FIG. 5 shows the result of analysis of the cellulose particles of the Comparative Examples 1 to 3 by XRD, and it could be confirmed that all particles were crystalline and thus, it could be judged that the cellulose particles obtained from water had crystallinity.
- Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose-insoluble liquid was changed to methanol. After a cellulose droplet dispersion was added to methanol in order to precipitate cellulose, the solution was settled to give a bilayer solution composed of a lower layer containing MCT and an upper layer containing methanol, 1-ethyl-3-methylimidazolium acetate and MCT. The precipitated cellulose was deposited in the upper layer. The cellulose was recovered, and it was found that the obtained cellulose was spherical cellulose particle having an average particle diameter of 60.4 ⁇ m and an average aspect ratio of 1.07.
- FIG. 18 shows the results of XRD analysis for the cellulose particles obtained in the Comparative Example 1 and Examples 1 to 3, and it could be judged that the cellulose particles were amorphous, except those obtained by using water as a solidification liquid in the Comparative Example 1.
- Cellulose particles were precipitated in the same condition and same manner as in the Example 3, except that the cellulose concentration was changed to 10.0 wt %. As a result, obtained were spherical cellulose particles having an average particle diameter of 54.23 ⁇ m and an average aspect ratio of 1.07. When the cellulose volume was compressed by 10%, the stress was 0.027 Mpa.
- FIG. 19 shows the results of XRD analysis for the cellulose particles obtained in the Examples 3 to 5, and all of the cellulose particles were amorphous.
- Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 12.0 wt % and the cellulose-insoluble liquid was changed to ethanol. As a result, obtained were spherical cellulose particles having an average particle diameter of 87.44 ⁇ m and an average aspect ratio of 1.07. Different from the case of using water or methanol, in the case of using ethanol, the solution was not separated into two layers.
- Crystalline cellulose (5.80 g) was dissolved in 1-ethyl-3-methylimidazolium acetate (52.18 g) at 70° C. to prepare a 10.0 wt % solution. From the cellulose solution, a volume of 50 mL was measured to be taken out. The measured amount of the solution was added to 950 mL of MCT that was stirred at a rate of 100 rpm by an H type blade having a blade diameter of 70 mm in a cylindrical container having an inner diameter of 113 mm, in order to be dispersed.
- the cellulose was recovered and washed with methanol and thereafter washed with water. Similarly to the Comparative Example 1, the obtained cellulose was observed with a microscope to find that obtained were cellulose particles having an average particle diameter of 86.3 ⁇ m and an average aspect ratio of 1.07. As shown in SEM photographs of FIGS. 20 and 21 , the particles were porous.
- the cellulose concentration in the solution was 10.9 wt %. From the cellulose solution, a volume of 15 mL was measured to be taken out.
- the measured amount of the solution was added to 85 mL of medium chain fatty acid triglyceride (MCT) (trade name: Acta M-2, fatty acid composition: 100% of C8, produced by Riken Vitamin Co., Ltd.) that was stirred at a rate of 400 rpm at 50° C.
- MCT medium chain fatty acid triglyceride
- cellulose particles were recovered and washed with ethanol and thereafter washed with water. Next, the cellulose particles were classified using a mesh of 125 ⁇ m to remove particles having a large particle diameter, and then classified using a mesh of 53 ⁇ m to remove particles having a small particle diameter. Further, a portion of the obtained cellulose particles was taken out, and the solvent thereof was substituted with 2-methyl-2-propanol. The obtained cellulose particles were dried by freeze drying, and then analyzed with a scanning electron microscope (S-4800, manufactured by Hitachi Ltd., hereinafter referred to as “SEM”). As a result, the cellulose particles were confirmed to be porous particles as shown in FIG. 22 .
- SEM scanning electron microscope
- the fine pore diameter of the obtained cellulose porous particles was determined by the above-described K av measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 725 angstroms and 271 angstroms, respectively.
- the inclination k was ⁇ 0.153.
- a value of K, measured by using IgG was 0.86.
- the exclusion limit molecular weight was 3.5 ⁇ 10 7 .
- the dried cellulose particles were analyzed by powder x-ray diffraction (XRD, Rigaku Mini Flex II, the same applies hereinafter), and the result showed an amorphous pattern.
- the average particle diameter was 94 ⁇ m.
- the fine pore diameter of the obtained cellulose porous particles was determined by the above-described K av measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 350 angstroms and 194 angstroms, respectively.
- the inclination k was ⁇ 0.266.
- the value of K av measured by using IgG was 0.93.
- the exclusion limit molecular weight was 3.8 ⁇ 10 6 .
- the average particle diameter was 88 ⁇ m.
- FIG. 24 shows the results of XRD analysis for the cellulose particles obtained in the Examples 8 to 10, and all of the cellulose particles were amorphous.
- the fine pore diameter of the obtained cellulose porous particles was determined by the above-described K av measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 362 angstroms and 201 angstroms, respectively.
- the inclination k was ⁇ 0.222.
- the value of K av measured by using IgG was 0.80.
- the exclusion limit molecular weight was 4.2 ⁇ 10 6 .
- XRD analysis was carried out to find that the obtained cellulose particles were amorphous.
- the average particle diameter was 90 ⁇ m.
- the fine pore diameter of the obtained cellulose porous particles was determined by the above-described K av measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 261 angstroms and 184 angstroms, respectively.
- the inclination k was ⁇ 0.380.
- the value of K av measured by using IgG was 0.86.
- the exclusion limit molecular weight was 1.5 ⁇ 10 6 .
- XRD analysis was carried out to find that the obtained cellulose particles were amorphous.
- the average particle diameter was 90 ⁇ m.
- the obtained cellulose particles were confirmed to be porous particles similar to the particles of the Example 8.
- the fine pore diameter of the obtained cellulose porous particles was determined by the above-described K av measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 1020 angstroms and 306 angstroms, respectively.
- the inclination k was ⁇ 0.117.
- the value of K av measured by using IgG was 0.79.
- the exclusion limit molecular weight was 1.0 ⁇ 10 8 .
- XRD analysis was carried out to find that the obtained cellulose particles were amorphous.
- the average particle diameter was 94 ⁇ m.
- the fine pore diameter of the obtained cellulose porous particles was determined by the above-described K av measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 1340 angstroms and 353 angstroms, respectively.
- the inclination k was ⁇ 0.102.
- the value of K av measured by using IgG was 0.78.
- the exclusion limit molecular weight was 2.3 ⁇ 10 8 .
- RO water was added to the obtained crosslinked porous particles to increase the total volume to 10 times as much as that of the crosslinked porous particles, and the mixture was sealed with two sheets of an aluminum foil and heated at 120° C. for 1 hour by using an autoclave (High pressure sterilizer ES-315, manufactured by TOMY SEIKO CO., LTD.). The mixture was allowed to cool down to room temperature, and then the porous particles were washed with RO water in a volume of 5 times as much as that of the porous particles on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), to obtain autoclaved porous particles B of which epoxy groups were transformed into glyceryl groups.
- a glass filter 11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.
- RO water was added to the obtained crosslinked porous particles to increase the total volume to 10 times as much as that of the crosslinked porous particles, and the mixture was put into an Erlenmeyer flask (300 mL) made of glass.
- the flask was sealed with two sheets of an aluminum foil, and the mixture was heated at 120° C. for 60 minutes by using an autoclave (High pressure sterilizer ES-315, manufactured by TOMY SEIKO CO., LTD.).
- the mixture was allowed to cool down to room temperature, and then the porous particles were washed with RO water in a volume of 5 times as much as that of the porous particles on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), to obtain autoclaved porous particles C.
- a glass filter 11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.
- RO water was added to the obtained crosslinked porous particles to increase the total volume to 10 times as much as that of the crosslinked porous particles, and the mixture was put into an Erlenmeyer flask (300 mL) made of glass.
- the flask was sealed with two sheets of an aluminum foil, and the mixture was heated at 120° C. for 60 minutes by using an autoclave (High pressure sterilizer ES-315, manufactured by TOMY SEIKO CO., LTD.).
- the mixture was allowed to cool down to room temperature, and then the porous particles were washed with RO water in a volume of 5 times as much as that of the porous particles on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), to obtain autoclaved porous particles D.
- a glass filter 11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.
- RO water was added to 11.0 mL of the crosslinked porous particles D obtained in the Example 15 to adjust the total volume to be 17.0 mL.
- the mixture was transferred to a 50 mL centrifugal tube.
- the centrifugal tube was installed in a mix rotor (Mix Rotor MR-3, manufactured by AS ONE Corporation) and the mixture was stirred at 25° C.
- 6.0 mL of a 8.64 mg/mL sodium periodate aqueous solution was prepared by dissolving sodium periodate (produced by Wako Pure Chemical Industries, Ltd.) in RO water and added to the centrifugal tube containing the porous particles D.
- the mixture was stirred at 25° C. for 1 hour.
- porous particles were washed with RO water on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.) until the electric conductivity of the filtrate became not more than 1 ⁇ S/cm, to obtain a formyl group-crosslinked porous carrier E.
- the electric conductivity of the washing filtrate was measured by a conductivity meter (ECTester 10 Pure+, manufactured by EUTECH INSTRUMENTS).
- a formyl group content in the obtained porous particles E was measured by the above-described method to find that the formyl group content was 20.17 ⁇ mol per 1 mL of the porous particles E.
- the solvent of the obtained formyl-crosslinked porous carrier E (9.0 mL) was substituted with 30 mL of a buffer of which pH was 11 and which contained 0.5 M trisodium citrate (produced by KANTO CHEMICAL CO., INC.) and 0.15 M sodium chloride (produced by KANTO CHEMICAL CO., INC.) on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.).
- the formyl group-containing porous carrier after substitution was put into a centrifugal tube, and the amount was adjusted to be 14.0 mL in total by volume.
- the pH of the reaction mixture was adjusted to be 5.0 by using 2.4 N citric acid (prepared from citric acid produced by KANTO CHEMICAL CO., INC. and RO water), and then the mixture was stirred at 6° C. for 4 hours by using a mix rotor (Mix Rotor MR-3, manufactured by AS ONE Corporation).
- a mix rotor Manufacturing Rotor MR-3, manufactured by AS ONE Corporation.
- 0.39 mL of a 5.5% dimethylamine borane (DMAB) aqueous solution prepared from dimethylamine borane produced by Kishida Chemical Co., Ltd. and RO water
- the porous carrier after the reaction was washed with RO water in a volume of 3 times as much as that of the porous carrier on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.).
- 0.1 N citric acid monohydrate prepared from citric acid monohydrate produced by KANTO CHEMICAL CO., INC. and RO water
- 0.1 N citric acid monohydrate was added to the porous carrier to adjust the total volume to be not less than 30 mL.
- the mixture was put into a centrifugal tube and washed with an acid while stirred at 25° C. for 30 minutes.
- the porous carrier was washed with RO water in a volume of 3 times as much as that of the porous carrier on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), and thereafter an aqueous solution of 0.05 M sodium hydroxide and 1 M sodium sulfate (prepared from sodium hydroxide produced by Nacalai Tesque, Inc., sodium sulfate produced by KANTO CHEMICAL CO., INC., and RO water) was added in a 3 times amount by volume. Next, an aqueous solution of 0.05 M sodium hydroxide and 1 M sodium sulfate was added to the porous carrier so as that the total volume was adjusted to be not lower than 30 mL. The mixture was put into a centrifugal tube and washed with alkali while stirred at room temperature for 30 minutes.
- the porous carrier was washed with RO water in a volume of 20 times as much as that of the porous carrier on a glass filter (11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.).
- 0.1 N citric acid monohydrate prepared from citric acid monohydrate produced by KANTO CHEMICAL CO., INC. and RO water
- a volume of 3 time as much as that of the porous carrier was added, and it was confirmed that the filtrate became neutral.
- the porous carrier was washed by using RO water until the electric conductivity of the washing filtrate became not more than 1 ⁇ S/cm, to obtain an adsorbent F as a target adsorbent on which a protein A was immobilized.
- the electric conductivity of the washing filtrate was measured by a conductivity meter (ECTester 10 Pure+, manufactured by EUTECH INSTRUMENTS).
- human polyclonal IgG (1500 mg/10 mL Gamma-Globulin Nichiyaku, produced by Nichiyaku) was selected, and the static binding capacity was measured. As a result, the static binding capacity was 83.9 mg/mL for the adsorbent. Further, the dynamic binding capacity was measured to find that the IgG adsorption capacity (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 29.8 mg/mL for the adsorbent. Further, the IgG adsorption capacity (5% dynamic binding capacity) at a linear rate of 150 cm/hour was 36.0 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 9 was used.
- the static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 85.9 mg/mL for the adsorbent.
- the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 6.9 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 10 was used.
- the static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 49.3 mg/mL for the adsorbent.
- the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 1.6 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 11 was used.
- the static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 79.3 mg/mL for the adsorbent.
- the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 9.3 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 12 was used.
- the static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 58.9 mg/mL for the adsorbent.
- the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 1.6 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 13 was used.
- the static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 83.9 mg/mL for the adsorbent.
- the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 12.8 mg/mL for the adsorbent.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Peptides Or Proteins (AREA)
Abstract
The objective of the present invention is to provide a method for easily producing a porous cellulose particle which can be used as an adsorbent for various substances in a safe manner without using a highly toxic solvent such as a calcium thiocyanate solution. In addition, the objective of the present invention is to provide a porous particle produced by the production method, an adsorbent which contains the porous particle and by which a highly pure protein can be efficiently purified in a safe manner, and a method for purifying a protein by using the adsorbent. The method for producing a porous particle according to the present invention is characterized in comprising the steps of preparing a solution containing cellulose and an ionic liquid; preparing a dispersion by dispersing the obtained cellulose solution into a liquid, wherein the liquid is not compatible with the ionic liquid; and coagulating the dispersion by bringing into contact with an alcohol or an alcohol aqueous solution in order in order to obtain the porous particle.
Description
- The present invention relates to a method for producing a porous particle, a porous particle produced by the production method, an adsorbent containing the porous particle, and a method for purifying a protein by using the adsorbent.
- A porous particle is widely used as a carrier for an adsorbent such as an adsorbent for various chromatography and an affinity adsorbent. Among such adsorbents, an affinity adsorbent is used as a medical adsorbent and an adsorbent for purifying a medical antibody, since an affinity adsorbent can efficiently purify a target substance and decrease a concentration of an unwanted substance.
- In particular, an adsorbent in which protein A is immobilized as an affinity ligand on a porous carrier is at the center of attention as an adsorbent for treating rheumatism, hemophilia and dilated cardiomyopathy (For example, Non-Patent
Document 1, Non-PatentDocument 2 and Non-Patent Document 3). In addition, an adsorbent in which protein A is immobilized on a porous carrier is also at the center of attention as an adsorbent on which an immunoglobulin, i.e. IgG, can be specifically adsorbed and which is used for purifying a medical antibody. - A polysaccharide is widely used as a material of a medical porous carrier, since a polysaccharide can be industrially produced without difficulty and the safety thereof in a living body is exceedingly high. For example, it is known that a porous cellulose carrier has excellent properties such as a relatively high mechanical strength, a number of hydroxy groups which can be utilized for binding ligands, a low non-specific adsorption and a higher safety in comparison with a synthetic polymer carrier (
Patent Documents 1 and 2). For example,Patent Document 3 discloses an adsorbent in which protein A is immobilized on a porous cellulose carrier. - However, a porous cellulose carrier is generally produced by dissolving cellulose in a highly toxic solvent such as a calcium thiocyanate solution, since there are few solvents which can dissolve cellulose. Such a solvent is difficult to be handled in terms of corrosion and safety.
- On the other hand, an ionic liquid is recently at the center of attention, since an ionic liquid is non-volatile and a liquid condition can be kept over a wide temperature region. An ionic liquid is mainly applied as a functional solvent, a solvent for an ionic device and a solvent for dissolving a material derived from a living body, such as a polypeptide. It is recently found that an ionic liquid can dissolve cellulose; therefore, an ionic liquid is applied for producing a fiber (Patent Document 4).
-
- Patent Document 1: JP H01-278534 A
- Patent Document 2: JP H11-158202 A
- Patent Document 3: WO 2008/146906
- Patent Document 4: JP 2008-248466 A
-
- Non-Patent Document 1: Annals of the New York Academy of Sciences, 2005, Vol. 1051, pp. 635-646
- Non-Patent Document 2: American Heart Journal, Vol. 152, No. 4, 2006
- Non-Patent Document 3: KASAI Kenichi et al., “Affinity chromatography” published by Tokyo Kagaku Dojin, 1991
- The objective of the present invention is to provide a method for easily producing a porous cellulose particle which can be used as an adsorbent for various substances in a safe manner without using a highly toxic solvent such as a calcium thiocyanate solution. In addition, the objective of the present invention is to provide a porous particle produced by the production method, an adsorbent which contains the porous particle and by which a highly pure protein can be efficiently purified in a safe manner, and a method for purifying a protein by using the adsorbent.
- The present inventors intensively studied so as to solve the above problems. As a result, the inventors found that an amorphous porous particle which has adequate size and an appropriate porosity as a material of a protein adsorbent can be efficiently produced in a safe manner by dissolving cellulose in an ionic liquid and contacting the obtained solution with a specific solvent, and completed the present invention.
- The method for producing a porous particle according to the present invention is characterized in comprising the steps of:
- preparing a solution containing cellulose and an ionic liquid;
- preparing a dispersion by dispersing the obtained cellulose solution into a liquid, wherein the liquid is not compatible with the ionic liquid; and
- coagulating the dispersion by bringing into contact with an alcohol or an alcohol aqueous solution in order to obtain the porous particle.
- In the step for preparing the cellulose solution in the present invention method, it is preferred that water and/or an alcohol is added and an amount of the water and/or alcohol to be added is adjusted to be not less than 2 wt % and not more than 20 wt % relative to a total amount with the ionic liquid. In the embodiment, it is possible to control an internal structure of the porous particle. Specifically, it is possible to uniformize a pore diameter of the porous particle by adding a poor solvent of cellulose to the solution.
- In the present invention method, it is preferred to adjust a temperature of the cellulose solution to be not less than 0° C. and not more than 70° C. When the temperature is not less than 0° C., a solubility of cellulose in an ionic liquid is high and it becomes easy to prepare the dispersion since a viscosity of the cellulose solution is low. In addition, when the temperature is not more than 70° C., the solvent other than the ionic liquid is hardly volatilized when the cellulose solution and the dispersion are prepared.
- It is preferred that the dispersion is brought into contact with the alcohol or the alcohol aqueous solution under the condition of not less than 10° C. For reasons that are unknown, the present inventors found that the higher the temperature is when the dispersion is brought into contact with the alcohol or the alcohol aqueous solution, the larger a micropore diameter of the obtained porous particle becomes. Therefore, the temperature is preferably not less than 10° C.
- The porous particle according to the present invention is characterized in being produced by the above-described present invention method.
- The adsorbent according to the present invention is characterized in comprising an affinity ligand and the porous particle according to the present invention, wherein the affinity ligand is immobilized on the porous particle.
- With respect to the porous particle and the adsorbent according to the present invention, it is preferred that a value of k is not more than −0.1 under the condition that the following formula (I) holds when the porous particle or the adsorbent is packed in a column, gel phase distribution coefficients of multiple proteins having equal or higher molecular weight as compared to a target substance to be adsorbed are measured, and measured values are plotted with Kav values on an abscissa and logarithm values of the molecular weights on an ordinate:
-
K av =k×ln(MW)+b (I) - wherein Kav represents the gel phase distribution coefficient, MW represents the molecular weight of the protein, and b represents a constant.
- When the value of k in the formula (I) is not more than −0.1, an adsorption capacity is becomes more excellent since a specific surface area relative to the molecular weight of the substance to be adsorbed becomes larger.
- With respect to the porous particle, it is preferred that the value of Kav of the target substance to be adsorbed, specifically IgG, measured by using a column packed with the porous particle is not less than 0.3. When the value of Kav is not less than 0.3, an adsorption capacity becomes more excellent since a specific surface area relative to the molecular weight of the substance to be adsorbed becomes larger.
- With respect to the porous particle and the adsorbent according to the present invention, it is preferred that an exclusion limit molecular weight is not less than 103 and not more than 109. When the exclusion limit molecular weight is included in the range, various useful proteins can be purified using the porous particle and the adsorbent according to the present invention.
- With respect to the adsorbent according to the present invention, it is preferred that an amount of the affinity ligand to be introduced is not less than 1 mg and not more than 1000 mg per mL of the porous particle. When the introduction amount is not less than 1 mL, the adsorbent may have a sufficient adsorption capacity more surely. On the other hand, the introduction amount is preferably not more than 1000 mg, since too much amount affinity ligand may not be possibly introduced onto the carrier and productivity may be possibly decreased in some cases.
- An amount of cellulose to be contained in the porous particle and the adsorbent according to the present invention is preferably not less than 2 wt % and not more than 50 wt %. When the content is not less than 2 wt %, the adsorbent which is hardly compressed when purification is carried out in large scale at high velocity can be obtained. In addition, when the content is not more than 50 wt %, sufficient pores through which a target substance to be purified can be passed can be ensured.
- It is preferred that the porous particle, which is a carrier of the adsorbent according to the present invention, is cross-linked. The cross-linked porous particle can be used at high linear velocity and under high pressure, since such a particle has a high strength.
- With respect to the porous particle and the adsorbent according to the present invention, it is preferred that a compressive stress when the porous particle or the adsorbent is compressed by 10% is not less than 0.01 MPa and not more than 3 MPa. When the compressive stress is not less than 0.01 MPa, the particle and the adsorbent are hardly compressed even when a liquid is passed through at high linear velocity. In addition, when the compressive stress is not more than 3 MPa, brittleness is improved and a microparticulate generation is inhibited more surely.
- A volume average particle diameter of the porous particle and the adsorbent according to the present invention is preferably not less than 1 μm and not more than 2000 μm. When the volume average particle diameter is not less than 20 μm, the particle and the adsorbent are hardly compressed more surely. When the volume average particle diameter is not more than 1000 μm, an amount of a target substance to be adsorbed may be increased.
- The affinity ligand of the adsorbent according to the present invention is preferably protein A.
- The method for purifying a protein according to the present invention is characterized in comprising the steps of:
- packing the above-described adsorbent according to the present invention into a column;
- allowing a solution containing a crude protein to pass through the adsorbent packed in the column; and
- allowing an eluent to pass through the column.
- By the present invention method, a cellulose porous particle can be produced more securely and at lower cost without using a calcium thiocyanate solution and the like, which are conventionally used. In addition, an ionic liquid used in the present invention method, instead of a calcium thiocyanate solution, and a liquid which is not compatible with the ionic liquid can be separated from each other to be recovered after use. The recovered liquids can be reused. Therefore, the present invention method is also suitable for an industrial mass production.
- In addition, by the present invention method, hardness and an internal structure of a cellulose porous particle can be improved. In particular, an amorphous cellulose porous particle can be obtained. Therefore, a cellulose porous particle which can be used as a carrier of an adsorbent for various substances can be provided by the present invention method.
- Furthermore, in the present invention method, a viscosity of the dispersion obtained from the cellulose solution depends on the liquid which is not compatible with the ionic liquid. Therefore, an apparent viscosity of the cellulose solution having a high concentration can be kept down during handling; as a result, the operatability of the solution can be significantly improved.
- In addition, the cellulose porous particle produced by the present invention method is very useful as a carrier of an adsorbent for a protein and the like.
-
FIG. 1 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Comparative Example 1. -
FIG. 2 is a photograph which was obtained by highly magnifying theFIG. 1 . -
FIG. 3 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Comparative Example 1. -
FIG. 4 is a photograph which was obtained by highly magnifying theFIG. 3 . -
FIG. 5 represents XRD patterns of the cellulose particles obtained in the Comparative Examples 1 to 3. -
FIG. 6 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 1. -
FIG. 7 is a photograph which was obtained by highly magnifying theFIG. 6 . -
FIG. 8 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 1. -
FIG. 9 is a photograph which was obtained by highly magnifying theFIG. 8 . -
FIG. 10 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 2. -
FIG. 11 is a photograph which was obtained by highly magnifying theFIG. 10 . -
FIG. 12 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 2. -
FIG. 13 is a photograph which was obtained by highly magnifying theFIG. 12 . -
FIG. 14 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 3. -
FIG. 15 is a photograph which was obtained by highly magnifying theFIG. 14 . -
FIG. 16 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 3. -
FIG. 17 is a photograph which was obtained by highly magnifying theFIG. 16 . -
FIG. 18 represents XRD patterns of the cellulose particles obtained in the Comparative Examples 1 and Examples 1 to 3. -
FIG. 19 represents XRD patterns of the cellulose particles obtained in the Examples 3 to 5. -
FIG. 20 is a SEM photograph of the torn surface of the cellulose particle according to the present invention obtained in the Example 7. -
FIG. 21 is a photograph which was obtained by highly magnifying theFIG. 20 . -
FIG. 22 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 8. -
FIG. 23 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 9. -
FIG. 24 is a SEM photograph of the surface of the cellulose particle according to the present invention obtained in the Example 10. -
FIG. 25 represents XRD patterns of the cellulose particles obtained in the Examples 8 to 10. - Hereinafter, the method of the present invention is described in the order depending on the exploitation.
- (1) Step for Preparing a Solution
- In the production method of the present invention, first, a solution containing cellulose and an ionic liquid is prepared.
- An ionic liquid is generally an ionic compound in the form of a liquid at lower than 100° C. under ordinary pressure. A cationic part of an ionic liquid is exemplified by pyridinium, imidazolium, imidazole and the like. An acyclic cation is exemplified by a quaternary alkyl ammonium, a quaternary alkyl phosphonium cation and the like. A counter anion of a cationic part is selected from the group consisting of a halogen ion, a pseudo halogen ion, an organic halide ion which is an organic compound containing a halogen, a carboxylate and the like. A carboxylate is exemplified by an acetate, a citrate, a malate, a maleate, a formate and an oxylate; a halogen ion is exemplified by a chloride, a bromide, a zinc chloride/a choline chloride; and an organic halide ion is exemplified by a tetrafluoroborate ion, a hexafluorophosphate ion, CF3SO2 −, (CF3SO2)2N−, CF3CO2 −, 3-methyl-N-butyl-pyridinium chloride and benzyldimethyl (tetradecy) ammonium chloride.
- Any cellulose which can be dissolved in an ionic liquid may be used in the present invention. For example, one or more kinds of celluloses selected from a regenerated cellulose, a crystalline cellulose or a microcrystalline cellulose, and cellulose acetate may be used. In particular, a crystalline cellulose having an average polymerization degree of not less than about 100 and not more than about 700 is preferred. When the average polymerization degree is not less than 100, the strength of the porous particles to be obtained can be made sufficient. On the other hand, when the average polymerization degree may be too high, the viscosity of the cellulose solution can be excessively high and therefore, the average polymerization degree is preferably not more than 700. The average polymerization degree is more preferably not less than 100 and not more than 500, furthermore preferably not less than 150 and not more than 350, and particularly preferably not less than 200 and not more than 300. In particular, a crystalline cellulose having an average polymerization degree of about 300 is preferred. In the case of using a crystalline cellulose with a high average polymerization degree, it is effective to add a poor solvent or to carry out operation at a high temperature for lowering the viscosity of the cellulose solution.
- An amount of cellulose to be used is not particularly limited and may be properly adjusted. For example, such an amount is preferably not less than 2 wt % and not more than 50 wt % relative to 100 wt % of the cellulose solution. When the concentration is not less than 2 wt %, an adsorbent which is not compacted even if purification is carried out at a high linear rate or in a large scale may be obtained. On the other hand, when the concentration is not more than 50 wt %, a sufficient pore through which a target substance to be purified can pass can be secured. In addition, when the concentration is too high, the viscosity of the solution may be so excessively high as to possibly worsen the operability and therefore, the concentration is preferably not more than 50 wt %. The concentration is more preferably not less than 3 wt %, furthermore preferably not less than 4 wt %, particularly preferably not less than 5 wt %, and more preferably not more than 30 wt %, furthermore preferably not more than 20 wt %, particularly preferably not more than 15 wt %.
- A method for preparing the solution is not particularly limited and a common method may be employed. For example, the solution may be prepared by simply mixing cellulose with an ionic liquid and heating or stirring the mixture until the cellulose is sufficiently dissolved.
- An inner structure of the porous particle can be controlled by adding one or more kinds selected from water and/or an alcohol to the solution containing cellulose and an ionic liquid to an extent that cellulose is not precipitated. More specifically, a pore diameter of the porous particle can be made more uniform by adding a poor solvent for cellulose to the solution.
- In the case where an alcohol aqueous solution is added, an alcohol concentration may be properly adjusted; and for example, a ratio of water:an alcohol may be set as [80:20] to [5:95] by volume.
- An amount of water and/or an alcohol to be added may be properly adjusted to an extent that cellulose is not precipitated at ordinary temperature and for example, the amount may be adjusted to be not less than 2 wt % and not more than 20 wt % relative to the total amount of an ionic liquid and water and/or an alcohol to be added. When the additive amount is not less than 2 wt %, an effect to make a pore diameter of the porous particle uniform is more reliably exerted. On the other hand, when the additive amount is too high, cellulose may be possibly precipitated and therefore, the additive amount is preferably not more than 20 wt %, and more preferably not more than 15 wt %.
- At the time of dissolving cellulose in an ionic liquid, the mixture may be heated. However, since a common ionic liquid is in a form of a liquid at lower than 100° C., it is preferred to keep the temperature lower than 100° C. The temperature is more preferably not less than 50° C. and not more than 90° C. In order to carry out the dissolution easily, cellulose may be previously microparticulated.
- (2) Dispersion Step
- Next, the obtained cellulose solution is dispersed in a liquid which is not compatible with the ionic liquid to prepare a dispersion.
- A temperature of the above-described cellulose solution is preferably adjusted to be not less than 0° C. and not more than 70° C. before or during dispersion in a liquid which is not compatible with the ionic liquid. When the temperature is not less than 0° C., a solubility of cellulose in the ionic liquid is high, and the viscosity of the cellulose solution is lowered so as to make the preparation of the dispersion easy. When the temperature is not more than 70° C., a solvent other than the ionic liquid is hardly evaporated at the time of preparation of the cellulose solution or the dispersion.
- It is preferred that not less than 1000 mL of a liquid which is not compatible with an ionic liquid is needed for dissolving 1 g or 1 mL of the employed ionic liquid at 25° C. Such a liquid may be selected depending on the kind of an ionic liquid to be used, and is exemplified by hexane, ethyl acetate, a C6-12 linear saturated fatty acid, a C16-24 unsaturated fatty acid, a fat and oil which is derived from an animal or a plant and of which melting point is not more than 100° C., a hydrogenated oil derived from an animal or a plant, a fractionated oil obtained by fractionizing and purifying a high melting point fraction of a fat and oil derived from an animal or a plant or a hydrogenated product thereof, a saturated fatty acid triglyceride, an edible wax, a microalgae-derived fat and oil, a microorganism fat and oil, a medium chain fatty acid triglyceride, an unsaturated fatty acid triglyceride, and the like. The fat and oil to be used for the present invention is not particularly limited as long as the fat and oil has a melting point of not more than 100° C. The fat and oil is exemplified by a fat and oil derived from an animal or a plant, such as a palm oil, a shea butter, a sal butter, an illipe butter, a lard, a tallow, a rapeseed oil, a rice oil, a peanut oil, an olive oil, a corn oil, a soybean oil, a perilla oil, a cotton seed oil, a sunflower oil, an evening primrose oil, a sesame oil, a safflower oil, a coconut oil, a cocoa butter, a palm kernel oil and a fish oil; a hydrogenated animal or plant oil such as a hydrogenated palm oil, an extremely hydrogenated palm oil, a hydrogenated rapeseed oil, an extremely hydrogenated rapeseed oil, a hydrogenated soybean oil, a hydrogenated lard oil and a hydrogenated fish oil; a fractionated oil obtained by fractionizing and purifying high melting point fraction of a fat and oil derived from an animal or a plant or a hydrogenated product thereof, such as a fractionated coconut oil, a fractionated palm kernel oil, a fractionated palm oil, a fractionated cocoa butter oil, a fractionated shea butter oil, a fractionated lard oil, a fractionated oil of a hydrogenated soybean oil, and a fractionated oil of a hydrogenated fish oil; a saturated fatty acid triglyceride, such as tristearin, tripalmitin and trilaurin; a partial glyceride of a fatty acid, such as a monoglyceride thereof and a diglyceride thereof; an edible wax such as a bees wax, a candelilla wax and a rice bran wax; a seaweed-derived fat and oil, such as an Undaria oil and a Laminaria oil; a microalgae-derived fat and oil, such as a Spirulina-extracted oil; a microorganism fat and oil, such as a yeast-extracted oil and a Mortierella-extracted oil; a fractionated oil obtained by fractionizing and purifying a low melting point fraction of the above-described oils and fats, such as a low melting point fraction of a palm oil, a low melting point fraction of a fish oil, and a low melting point fraction of a shea butter; a medium chain fatty acid triglyceride such as tricaprylin and tricaprin; an unsaturated fatty acid triglyceride such as triolein and trilinolein; a partial glyceride such as a monoglyceride thereof and a diglyceride thereof; and a fatty acid such as oleic acid, linoleic acid, linolenic acid, arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid.
- Only one kind of the above-described liquid which is not compatible with an ionic liquid may be used alone, or two or more kinds may be used in the form of a mixture. The examples of the case of mixing two or more kinds may include a mixed solvent of saturated fatty acids with different numbers of carbon atoms, a mixed solvent of unsaturated fatty acids with different numbers of carbon atoms, and a mixed solvent of a saturated fatty acid and an unsaturated fatty acid.
- A surfactant may be used for dispersing an ionic liquid in a liquid which is not compatible with the ionic liquid. Such a surfactant is exemplified by N-acyl-L-glutamic acid triethanolamine, sodium N-acyl-L-glutamate, an alkyldiaminoethylglycine hydrochloride liquid, dimethicone copolyol, polyoxyethylene octyl phenyl ether, polyoxyethylene stearyl ether, polyoxyethylene cetyl ether, polyoxyethylene-polyoxypropylene glycol, glyceryl monostearate, propylene glycol monostearate, polyoxyethylene glyceryl monostearate, polyoxyethylene sorbitan monostearate, polyethylene glycol monophosphate and the like. From the viewpoints of coloration suppression on cellulose, solution viscosity and the like, a medium chain fatty acid triglyceride is preferred as a surfactant.
- Droplets of the cellulose solution are formed by dispersing the cellulose solution in the above-described liquid. The use amounts of the cellulose solution and a liquid which is not compatible with the ionic liquid are not particularly limited and may be properly adjusted, and a ratio of the liquid:the cellulose solution may be adjusted to be [98:2] to [50:50] by volume.
- The volume ratio is preferably [97:3] to [70:30], and more preferably [97:3] to [80:20].
- A method for dispersing the cellulose solution is not particularly limited, and for example, the cellulose solution can be homogeneously dispersed in a liquid which is not compatible with the ionic liquid by stirring using a stirring blade or a homogenizer. A static mixer can also be employed.
- (3) Solidification Step
- Next, the above-mentioned dispersion is solidified by bringing into contact with an alcohol or an alcohol aqueous solution to obtain porous particles. In the present step, an ionic liquid in the droplets is extracted to insolubilize and condense cellulose and thus porous particles consisting of cellulose can be obtained.
- An alcohol to be employed in the present step is exemplified by a C1-6 alcohol such as methanol, ethanol, 1-propanol, 2-propanol, n-butanol, isobutanol, 2-butanol, sec-butanol, 2-methyl-2-propanol (tert-butanol), 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butanol, 3-methyl-1-butanol, 2-methyl-2-butanol, 3-methyl-2-butanol, 1-hexanol, 2-hexanol, 3-hexanol and the like.
- A concentration of an alcohol aqueous solution is not also particularly limited and may be properly adjusted, and for example, a ratio of water:an alcohol may be adjusted to be [80:20] to [5:95] by volume. Surprisingly, the inventors of the present invention found that fine pores of the porous particle become larger as the volume ratio of water in the alcohol aqueous solution is higher, and that the sphericity of the porous particles becomes higher and the porous particles become more amorphous as the volume ratio of alcohol is higher. From the viewpoints, the volume ratio is more preferably [70:30] to [10:90], furthermore preferably [50:50] to [10:90], and particularly preferably [40:60] to [20:80].
- A method for bringing the above-described dispersion into contact with an alcohol or an alcohol aqueous solution is not particularly limited, and the entire amount of the alcohol or the alcohol aqueous solution may be added to the dispersion, a portion of the alcohol or the alcohol aqueous solution may be added step by step to the dispersion, the entire amount of the dispersion may be added to the alcohol or the alcohol aqueous solution, or a portion of the dispersion may be added step by step to the alcohol or the alcohol aqueous solution. Preferably, the dispersion is gradually added to a stirred alcohol or alcohol aqueous solution.
- An amount of an alcohol or an alcohol aqueous solution to be used is not particularly limited and may be a sufficient amount to extract the ionic liquid, and for example, the volume ratio of the alcohol or alcohol aqueous solution relative to the dispersion may be adjusted to be not less than 1 and not more than 5.
- A temperature at the time of the contact is not also particularly limited and is preferably adjusted to be not less than the melting point of the ionic liquid and not more than the boiling point of an alcohol to be used. When the temperature is adjusted to not more than the melting point of the ionic liquid, it may possibly become difficult to release the ionic liquid from the cellulose particles. On the other hand, when the temperature is adjusted to not less than the boiling point of the alcohol, it results in increased costs since to a refluxing apparatus or the like is necessary. The temperature is preferably not less than 10° C. and not more than 60° C., more preferably not less than 25° C. and not more than 60° C., and particularly preferably not less than 40° C. and not more than 55° C. Additionally, a porosity of the solidified cellulose particle is surprisingly affected by the temperature of the cellulose solution and either the alcohol or the alcohol aqueous solution, and a fine pore diameter of the cellulose particle becomes larger as the solution temperature is higher. Also in the point, the temperature is preferably adjusted within the above-described preferred range.
- With respect to a fine pore diameter of the porous cellulose particle, for example, the maximum diameter thereof is preferably not less than 200 angstroms and not more than 1500 angstroms, and the average diameter thereof is preferably not less than 100 angstroms and not more than 400 angstroms. The average diameter is more preferably not less than 140 angstroms and not more than 400 angstroms, and furthermore preferably not less than 200 angstroms and not more than 400 angstroms.
- The cellulose particle obtained in the above-described manner is porous, and the size of the pore and the hardness thereof can be controlled by changing a cellulose concentration, a dispersion temperature, and a cellulose-insoluble liquid.
- (4) Recovery Step
- Next, the obtained porous particle may be recovered. A means for recovery is not particularly limited, and a common solid-liquid separation means such as filtration and centrifugation may be employed.
- The obtained porous particle may be washed with water or an alcohol and thereafter dried in reduced pressure in order to remove the ionic liquid and the cellulose-insoluble liquid remaining in the pores if necessary.
- The used ionic liquid can be recovered by evaporating the cellulose-insoluble liquid from the obtained liquid by solid-liquid separation.
- (5) Crosslinking Step
- The porous particle obtained by the above-described method of the present invention can be further improved in strength by a crosslinking agent. Such crosslinking agent and crosslinking reaction condition are not particularly limited, and known techniques can be employed. The crosslinking agent is exemplified by a halohydrine such as epichlorohydrin, epibromohydrin and dichlorohydrin; a bifunctional bisepoxide (bisoxirane); and a polyfunctional polyepoxide (polyoxirane).
- The size of the porous particle is not particularly limited, and in general, is preferably not less than about 1 μm and not more than about 2 mm. For example, when the porous particle is used as an adsorbent carrier for purification, a volume average particle diameter is preferably not less than 20 μm and not more than 1000 μm. When the volume average particle diameter of the porous particle is not less than 20 μm, compaction is difficult to be caused. When the volume average particle diameter is not more than 1000 μm, an adsorption amount of a target substance to be purified is increased in the case where the porous particles are used for an adsorbent carrier for purification. The volume average particle diameter of the porous particle is more preferably not less than 20 μm, furthermore preferably not less than 30 μm, particularly preferably not less than 50 μm, most preferably not less than 60 μm, and more preferably not more than 500 μm, furthermore preferably not more than 250 μm, particularly preferably not more than 125 μm, most preferably not more than 95 μm. The volume average particle diameter can be determined by measuring the particle diameter of randomly selected 100 porous particles. The particle diameter of each porous particle can be measured by photographing a microscopic photograph of each porous particle, saving the photograph in the form of electronic data, and carrying out an analysis using a particle diameter measurement software such as Image-Pro Plus manufactured by Media Cybernetics, Inc. Alternatively, the measurement can also be carried out by using a laser diffraction/scattering particle size distribution measuring device. The size of the porous particle can be controlled by the stirring intensity, the kind of a surfactant or the like at the time of the dispersion or at the time of bringing the dispersion into contact with an alcohol or an alcohol aqueous solution.
- Next, a method for producing an adsorbent is described. In the method, the cellulose porous particle obtained in the above-described manner is used as a carrier.
- (6) Step for Immobilizing Affinity Ligand
- In order to produce an adsorbent to adsorb a protein, an affinity ligand which has high affinity to a target substance to be adsorbed is immobilized on the above-described porous cellulose particle.
- An affinity ligand means a molecule or a compound which is interacted with a specific target substance and is capable of having a specific affinity to the specific target substance. For example, when an antibody is a target substance to be adsorbed, an affinity ligand is exemplified by an antigen and a protein which cause specific interaction, a peptide having antibody bonding activity, and the like.
- An affinity ligand to be used for the adsorbent of the present invention is not particularly limited, and various affinity ligands can be immobilized by using a porous carrier which is activated for immobilizing a desired affinity ligand. A method of immobilization is exemplified by a method for immobilizing an amino group-containing ligand by employing a cyanogen bromide method, a trichlorotriazine method, an epoxy method, a tresyl chloride method, a periodate oxidation method, a divinylsulfonic acid method, a benzoquinone method, a carbonyl diimidazole method, an acyl azide method and the like; a method for immobilizing a hydroxy group-containing ligand by employing an epoxy method, a diazo coupling method and the like; a method for immobilizing a thiol group-containing ligand by employing an epoxy method, a tresyl chloride method, a divinylsulfonic acid method and the like; a method for immobilizing a carboxylic acid-containing ligand or a formyl group-containing ligand on an aminated carrier; and the like, which are described in Table 8-1, Table 8-2 and FIG. 8-15 of
Non-Patent Document 3. - The adsorbent of the present invention can be used as an adsorbent for purification and can also be used as an adsorbent for purifying an antibody pharmaceutical product, which has drawn attention in recent years. An affinity ligand to be used for purifying an antibody pharmaceutical product is not particularly limited, and is exemplified by an antigen and a protein which have high specificity to an antibody, protein G, protein L, a variant thereof, and an amino group-containing ligand such as a peptide having an antibody bonding activity.
- In particular, as an adsorbent which can specifically adsorb and elute an immunoglobulin (particularly, IgG), an adsorbent obtained by immobilizing protein A as an affinity ligand on a porous carrier is drawing attention. The protein A to be used for the present invention is not particularly limited, and a natural protein A, a gene recombinant protein A and the like can be used without limitation. In addition, protein A may include an antibody bonding domain and a variant thereof, and may be a fusion protein and the like. Furthermore, it is also possible to use protein A which is produced from a microbe extract or a culture supernatant by combining and/or repeating purification methods selected from a molecular weight fraction method and fractional precipitation method which employs various kinds of chromatography such as ion exchange chromatography, hydrophobic interaction chromatography, gel filtration chromatography and hydroxyapatite chromatography, and a membrane separation technique. In particular, protein A obtained by the method disclosed in WO 2006/004067, U.S. Pat. No. 5,151,350 B, WO 2003/080655, JP 2006-304633 A or Japanese Patent Application No. 2009-071766 is preferred.
- A method for introducing protein A as an affinity ligand into the porous particle can be selected from the various immobilization methods as described above, and a method of immobilization by utilizing the reaction of a formyl group which is possessed by the porous particle and the amino group of protein A is more preferred. For example, a method described in
Patent Document 1 can be used. - An amount of an affinity ligand to be introduced into the adsorbent of the present invention is not particularly limited, and for example, may be adjusted to be not less than 1 mg and not more than 1000 mg per 1 mL of the porous carrier. When the ratio is not less than 1 mg, the adsorption amount for a target substance to be purified may be preferably increased. When the ratio is not more than 1000 mg, a production cost may be preferably suppressed. The amount of the affinity ligand to be introduced is more preferably not less than 2 mg, furthermore preferably not less than 4 mg, particularly preferably not less than 5 mg, and more preferably not more than 500 mg, furthermore preferably not more than 250 mg, particularly preferably not more than 200 mg, most preferably not more than 100 mg per 1 mL of the porous carrier.
- Hereinafter, preferred physical properties of the porous particle in the case where the porous particle is used as a porous carrier for the adsorbent is described.
- When the porous particle is used for the adsorbent, a fine pore diameter thereof is one of important factors. For example, when a fine pore diameter is smaller than a target substance to be adsorbed, adsorption is caused only on the surface of the adsorbent carrier and an adsorption amount may possibly become low. On the other hand, when a fine pore diameter is too large, a specific surface area becomes small and an adsorption amount may possibly become low. Accordingly, the porous carrier which has a proper fine pore diameter for a target substance to be adsorbed is preferred.
- One of the physical properties with respect to a fine pore diameter of the porous particle is Kav. Kav means a gel phase distribution coefficient, and is a variable number which is independent from a column and which is calculated in accordance with the following formula from an elution or retention volume VR (expressed also as Ve) for molecules in a prescribed size, a void volume Vo and a geometrical volume Vc of a column.
-
K av=(V R −V o)/(V t −V o) - (for example, refer to “Handbook of Process Chromatography, A Guide to Optimization, Scale-Up and validation” (1997) Academic Press, San Diego. Gail Sofer & Lars Hagel eds. ISBN0-12-654266-X, p. 368)
- The reason for using Kav value but not an accurate value of a fine pore diameter is because it is difficult to accurately measure the fine pore diameter when the porous particles are dispersed in a solvent and made into a wet state like a gel for column chromatography, and an estimated fine pore diameter measured in a dry state cannot accurately reflect a fine pore diameter in a wet state.
- An adsorption amount can be improved by immobilizing an affinity ligand on the porous carrier which shows a straight line with an inclination of not more than −0.1 in a range of molecular weight of equal to or more than the molecular weight of a target substance to be adsorbed when Kav values are plotted on the abscissa and the logarithm values of the molecular weights are plotted on the ordinate. In other words, an adsorbent obtained by immobilizing an affinity ligand on the porous carrier of which value of k is not more than −0.1 (k=−0.1 or k<−0.1) under the condition that the following formula (I) holds in a molecular weight region of equal to or more than the molecular weight of a target substance to be adsorbed.
-
K av =k×ln(MW)+b (I) - wherein k represents an inclination, MW represents a molecular weight of a marker when Kav is measured, and b represents a constant.
- When a value of k is smaller in the formula (I), a specific surface area for a molecular weight of a substance to be adsorbed becomes larger, and thus an adsorption amount can be increased. Accordingly, a value of k is preferably not more than −0.15, more preferably not more than −0.20, furthermore preferably not more than −0.30, and particularly preferably not less than −5.0 and not more than −0.35.
- It is preferred that a value of Kav for a molecular weight of a target substance to be adsorbed is not less than 0.3. When a value of Kav for a molecular weight of a target substance to be adsorbed is not less than 0.3, a specific surface area for the molecular weight of the substance to be adsorbed becomes larger, and efficient adsorption is made possible. A value of Kav is more preferably not less than 0.55, furthermore preferably not less than 0.65, and particularly preferably not less than 0.75. In addition, a value of Kav is preferably not more than 0.94. When a value of Kav is more than 0.94, a resin content is lowered and a strength of the adsorbent may possibly be lowered.
- It is preferred that an exclusion limit molecular weight of the porous carrier is higher than a molecular weight of a target substance to be adsorbed. However, when a fine porous diameter is large and an exclusion limit molecular weight is rather much larger than a molecular weight of a target substance to be adsorbed, adsorption efficiency may be lowered. For example, when the adsorbent is used for purification, a target substance to be adsorbed is often a protein and generally, a molecular weight of a protein is not less than about 103 and not more than about 108 and therefore, it is preferred that an exclusion limit molecular weight is set to be not less than about 103 and not more than about 109. For example, when IgG is a target substance to be adsorbed, it is preferred that an exclusion limit molecular weight is set to be not less than about 106 and not more than about 108.
- An exclusion limit molecular weight can be determined by employing a conventionally known method. For example, an exclusion limit molecular weight is a molecular weight when Kav is 0, and therefore can be determined according to the following formula (II) obtained by substituting 0 for Kav in the above-described formula (I).
-
Exclusion limit molecular weight=exp(−b/k) (II) - In order to accurately measure physical properties relevant to a fine pore diameter, such as Kav and an exclusion limit molecular weight, it is preferred to carry out the measurement by using a compound which is not adsorbed to the adsorbent, and it is more preferred to carry out the measurement by using the porous particle before immobilization of a ligand. When the measurement is carried out using the adsorbent, it is necessary to carry out the measurement using a compound which has a similar molecular weight to a target substance to be adsorbed, or to predict the result by carrying out the measurement using compounds which have molecular weights smaller and higher than that of a target substance to be adsorbed and forming a straight line between two points obtained by the measurement. A marker compound to be used for the measurement is preferably a compound which is analogous with a target substance to be adsorbed. For example, when a synthetic polymer such as polystyrene is compared with a protein, even if the molecular weights thereof are same, the volumes thereof are different in a measurement solution. Accordingly, for example, when a target substance to be adsorbed is an antibody, it is preferred to use a protein as a marker compound.
- According to the above-described method of the present invention, a porous particle which has high cellulose content can be produced, since a cellulose solution with high concentration can be prepared by using an ionic liquid. Such a porous particle cannot be obtained by a conventional method. In general, when resin content is high, an adsorbent which does not cause compaction can be obtained. Cellulose content per packing volume of the present invention adsorbent is not particularly limited, and is preferably not less than 2 wt % and not more than 50 wt %. When cellulose content per packing volume is not less than 2 wt %, it is possible to preferably obtain an adsorbent which does not cause compaction even if purification is carried out at a high linear rate or in a large scale. On the other hand, when cellulose content per pecking volume is not more than 50 wt %, sufficient pores which are preferably capable of passing a target substance to be purified can be secured. A cellulose content per packing volume is more preferably not less than 3 wt %, furthermore preferably not less than 4 wt %, and more preferably not more than 25 wt %, furthermore preferably not more than 15 wt %. Cellulose content per packing volume can be determined according to the following formula (III) as follows. That is, the porous particles are packed by precipitation until a volume of the porous particles is not further decreased, and a porous particle amount is adjusted so that the porous particle volume is 1 mL. The particles are dried at 105° C. for 12 hours, and the dry weight percent per 1 mL of gel, that is, the cellulose content, can be determined from a dry weight (g) per packing volume.
-
Cellulose content (%)=[dry weight (g)/packing volume (mL)]×100 (III) - It is preferred that a compressive stress when the adsorbent of the present invention is compressed by 5% is not less than 0.005 MPa and not more than 1 MPa, a compressive stress when the adsorbent is compressed by 10% is not less than 0.01 MPa and not more than 3 MPa, and a compressive stress when the adsorbent is compressed by 15% is not less than 0.03 MPa and not more than 5 MPa. If a compressive stress when the adsorbent is compressed by 5% is not less than 0.005 MPa and a compressive stress when compressed by 10% is not less than 0.01 MPa and a compressive stress when compressed by 15% is not less than 0.03 MPa, it is easy to obtain an adsorbent which does not cause compaction even if a liquid is introduced at a high linear rate. If a compressive stress when the adsorbent is compressed by 5% is not more than 1 MPa and a compressive stress when compressed by 10% is not more than 3 MPa and a compressive stress when compressed by 15% is not more than 5 MPa, a brittleness is preferably improved and fine particle generation can be preferably suppressed. In the present invention, a compressive stress when compressed by 5% means a stress at the time of 5% decrease in volume from the initial volume when the adsorbent is compressed; a compressive stress when compressed by 10% means a stress at the time of 10% decrease in volume from the initial volume when the adsorbent is compressed; and a compressive stress when compressed by 15% means a stress at the time of 15% decrease in volume from the initial volume when the adsorbent is compressed. The initial volume is a volume in a state where the adsorbent is deposited to be packed until a volume of the adsorbent is not further decreased while applying vibration to a slurry containing the adsorbent. A compressive stress when the adsorbent is compressed can be measured by the following method.
- 1) The adsorbent is added with water in an amount to allow the entire volume to be 2 times to produce a slurry, and the slurry is loaded into a graduated cylinder made of glass having an inner diameter of 15 mm.
2) The adsorbent is deposited to be packed until a volume of the adsorbent is not further decreased by applying vibration to the graduated cylinder made of glass, and an amount of the adsorbent is adjusted so that a volume of the adsorbent is about 4 mL. The volume at the time is defined as the initial volume.
3) A piston made of a metal which does not cause friction with the inner wall of the graduated cylinder and which is processed to prevent elution of the adsorbent is attached to an autograph (EZ-TEST, manufactured by SHIMADZU CORPORATION) equipped with a load cell for 20N.
4) The position of the piston is adjusted so that the bottom surface of the piston is moved to the position corresponding to 120 vol % of the adsorbent.
5) The piston is lowered at a testing rate of 5 mm/min in a manner of preventing entrainment of bubbles, and the porous carrier is compressed and the volume is decreased.
6) The compressive stress at a prescribed point is measured. - The adsorbent obtained by immobilizing an affinity ligand on the porous carrier having the above-described physical properties is expected to efficiently adsorb a target substance to be adsorbed at a high linear rate and in a large scale.
- The adsorbent of the present invention is preferably has an adsorption amount of a target substance to be adsorbed of not less than 1 mg per 1 mL of the adsorbent. When the adsorption amount of a target substance to be adsorbed is not less than 1 mg per 1 mL of the adsorbent, purification can be preferably carried out efficiently. On the other hand, when the adsorption amount of a target substance to be adsorbed is not more than 1000 mg per 1 mL of the adsorbent, an adsorbed target substance can be easily eluted from the adsorbent. The adsorption amount of a target substance to be adsorbed by the adsorbent is more preferably not less than 5 mg, furthermore preferably not less than 10 mg, particularly preferably not less than 20 mg, most preferably not less than 30 mg, and preferably not more than 500 mg, furthermore preferably not more than 300 mg, particularly preferably not more than 250 mg, most preferably not more than 200 mg per 1 mL of the adsorbent.
- An amount of a target substance to be adsorbed can be determined as follows. A method for determining an adsorption amount of a target substance is not particularly limited, and an adsorption amount can be determined as a static adsorption amount or as a dynamic adsorption amount. For example, a static adsorption amount can be determined by bringing a solution obtained by dissolving 70 mg of a target substance to be adsorbed in 35 mL of a phosphate buffer (produced by Sigma) having a pH of 7.4 into contact with 0.5 mL of an adsorbent of which solvent is substituted with a phosphate buffer (produced by Sigma) having a pH of 7.4, stirring the mixture at 25° C. for 2 hours, and then measuring a decreased amount of the target substance to be adsorbed in a supernatant.
- Further, one example of a method for determining a dynamic adsorption amount of a target substance to be adsorbed and a concentration of a ligand which is leaked in the target substance is described as follows.
- (1) Preparation of Solution
- The following solutions are prepared:
- A solution: a phosphate buffer which has a pH of 7.4 (produced by Sigma);
B solution: 35 mM sodium acetate which has a pH of 3.5 (prepared from acetic acid and sodium acetate produced by Wako Pure Chemical Industries, Ltd. and RO water);
C solution: 1 M acetic acid (prepared from acetic acid produced by Wako Pure Chemical Industries, Ltd. and RO water);
D solution: a 1 mg/mL human polyclonal IgG solution (prepared from Gammagard produced by Baxter and the A solution);
E solution: 6 M urea;
F solution: a liquid obtained by adding 0.2 vol % of a surfactant (polyoxyethylene (20) sorbitan monolaurate, produced by Wako Pure Chemical Industries, Ltd.) to the A solution;
Neutralizing solution: 2M tris(hydroxymethyl)aminomethane (prepared from tris(hydroxymethyl)aminomethane produced by Sigma and RO water). - The respective solutions are defoamed before use.
- (2) Packing and Preparation
- As a column chromatography apparatus, AKTA explorer 100 (manufactured by GE Healthcare Bioscience) is used. A mesh of 22 μm is attached to a column having a diameter of 0.5 cm and a height of 15 cm. Into the column, 3 mL of each adsorbent of the present invention is loaded and packed by passing a 20% ethanol aqueous solution (prepared from ethanol produced by Wako Pure Chemical Industries, Ltd. and RO water) at a linear rate of 400 cm/hr for 1 hour. Sampling tubes having a volume of 15 mL are set to a fraction collector, and sampling tubes for an effluent are previously filled with the neutralizing solution.
- (3) Washing
- If necessary, the respective solutions in an amount of 3 times as much as that of the adsorbent are allowed to pass at a linear rate of 300 cm/hr in the order of the F solution, the B solution, the A solution, the C solution and the E solution. The solution passing cycle is repeated an arbitrary number of times.
- (4) IgG Purification
- The A solution in an amount of 9 mL is allowed to pass at a linear rate of 300 cm/hr and subsequently, while monitoring UV, the D solution is allowed to pass at a linear rate of 300 cm/hr until 10% of IgG is eluted. Next, 30 mL of the A solution is allowed to pass at a linear rate of 300 cm/hr and 30 mL of the B solution is allowed to pass at a linear rate of 300 cm/hr to elute IgG. Subsequently, 9 mL of the C solution is allowed to pass at linear rate of 300 cm/hr and 9 mL of the E solution is allowed to pass at linear rate of 300 cm/hr. The operation after completion of the packing of the adsorbent is repeated further 2 times to measure the IgG amount in the effluent and the concentration of the ligand which leaks in IgG.
- The adsorbent of the present invention can be used for purifying various kinds of target substances such as a protein by employing affinity chromatography, for various kinds of purification method as disclosed in
Non-Patent Document 3, and for an adsorbent of therapy and an adsorbent for medical treatment. A purification method or a therapeutic method is not particularly limited, and the methods disclosed in 1, 2 and 3 and other known methods can be preferably applied.Non-Patent Documents - In the purification method in which the adsorbent for purification according to the present invention is used, it is preferred that a column having a diameter of not less than 0.5 cm and a height of not less than 3 cm is used. When the diameter is not less than 0.5 cm and the height is not less than 3 cm, purification can be carried out efficiently. From the viewpoint of an accuracy and efficiency of purification, a size of the column is preferably not more than 2000 cm in diameter and not more than 5000 cm in height. A size of a column is more preferably not less than 2 cm and not more than 400 cm in diameter and not less than 5 cm and not more than 400 cm in height, furthermore preferably not less than 5 cm and not more than 300 cm in diameter and not less than 8 cm and not more than 200 cm in height, particularly preferably not less than 10 cm and not more than 250 cm in diameter and not less than 12 cm and not more than 100 cm in height, and most preferably not less than 20 cm and not more than 150 cm in diameter and not less than 15 cm and not more than 50 cm in height.
- Therapy or purification in which the adsorbent of the present invention is used preferably comprises the step of allowing a liquid to pass at a linear rate of not less than 10 cm/hr. When the step of allowing a liquid to pass at a linear rate of not less than 10 cm/hr is involved, therapy or purification can be carried out efficiently. From the viewpoints of an accuracy of therapy or purification and a durability of apparatus, therapy or purification using the adsorbent of the present invention is preferably carried out at a linear rate of not more than 5000 cm/hr. The linear rate for purification is more preferably not less than 50 cm/hr, furthermore preferably not less than 100 cm/hr, particularly preferably not less than 200 cm/hr, most preferably not less than 300 cm/hr, and more preferably not more than 3000 cm/hr, furthermore preferably not more than 1500 cm/hr, particularly preferably not more than 1000 cm/hr, most preferably not more than 750 cm/hr.
- Hereinafter, examples of the present invention are described; however, the present invention should not be limited to the examples.
- A tapped volume is used for representing a volume of the porous particle which was used for a reaction when the adsorbent according to the present invention was produced, unless otherwise specified. A tapped volume is a volume of the porous particle under the condition that a slurry of the porous particle and RO water is added into a measuring container and the porous particles are deposited until the volume is not decreased any more while applying vibration. A volume of the porous particle as a base of a ratio of a functional group is also a tapped volume unless otherwise specified. In the case where the porous particle was deficient in respective tests, the porous particle was produced in the same manner to be added.
- First, the measurement conditions for physical properties of the respective porous particles are described.
- Porous particles (4 mL) of which solvent was substituted with a 0.1 M phosphate buffer having a pH of 8 were brought into contact with 2 mL of a 0.1 M phosphate buffer solution having a pH of 8 in which phenylhydrazine was dissolved, and the mixture was stirred at 40° C. for 1 hour. Next, the maximum absorbance of the supernatant of the reaction mixture around 278 nm was measured by UV absorbance measurement. From the measurement result, the formyl group content was estimated as the adsorption amount of phenylhydrazine to the porous particles. At the time, the loading amount of phenylhydrazine was adjusted to be 3 times by mole as much as that of the expected formyl group content. When the adsorption amount to the porous particles was not more than 15% or not less than 45% relative to the loading amount of phenylhydrazine, the loading amount of phenylhydrazine was reexamined and the measurement was to be carried out again.
- (1) Packing into Column
- Porous particles were dispersed in RO water and degassed for 1 hour. The degassed porous particles were packed in a column (
Tricorn 10/300, manufactured by GE Healthcare Japan) at a linear rate of 105 cm/hr. Thereafter, an eluent (129 mL) having a pH of 7.5 was allowed to pass through the column at a linear rate of 26 cm/hr. - (2) Addition of Marker
- The followings were used as a marker.
- Blue Dextran 2000 (manufactured by Pharmacia Fine Chemicals)
- Low Density Lipoprotein (manufactured by Sigma), MW 3,000,000
- Thyroglobulin (manufactured by Sigma), MW 660,000
- Ferritin (manufactured by Sigma), MW 440,000
- Aldolase (manufactured by Sigma), MW 158,000
- Human IgG (manufactured by Sigma), MW 115,000
- Bovine Serum Albumin (manufactured by Wako), MW 6,700
- Cytochrome C (manufactured by Wako), MW 12,400
- Bacitracin (manufactured by Wako), MW 1,400
- The above-described markers were diluted with a buffer having a pH of 7.5 so that the concentrations were adjusted to be 5 mg/mL. While the above-described eluent was allowed to pass through the column at a linear rate of 26 cm/hr, each 12 μL of the diluted solutions were injected. The concentration of each marker was finely adjusted as necessary.
- (3) Measurement
- As a measurement apparatus, DGU-20A3, SCL-10A, SPD-10A, LC-10AD, SIL-20AC, CTO-10AC (all of which were manufactured by SHIMADZU CORPORATION) were used, and LC Solution was used as measurement software. For a liquid volume measurement, a 50 mL-graduated cylinder was used.
- Simultaneously with the marker injection, monitoring with UV and measurement of the liquid volume were started in accordance with the following conditions.
- 1) A liquid volume corresponding to the first peak for Blue Dextran was defined as V0 (mL).
- 2) A liquid volume corresponding to the peak for each marker was defined as VR (mL).
- 3) A total volume of the porous particles in the column was defined as Vt (mL).
- (4) Calculation
- A gel phase distribution coefficient (Kav) of each marker was calculated according to the following formula.
-
K av=(V R −V o)/(V t −V o) - (5) Maximum Diameter
- The values of Kav and logarithm of the molecular weight of each marker were plotted, and the inclination and the intercept of the following formula were determined from the portion showing linearity.
-
K av =k×ln(MW)+b (I) - Subsequently, from the measured inclination and the intercept, the molecular weight when a value of Kav is 0, that is, an exclusion limit molecular weight, was determined. Next, the following correlation equation of a diameter and a molecular weight of a spherical protein in a neutral buffer was substituted with the exclusion limit molecular weight, and the calculated value was defined as the maximum diameter of the pores of sample particles.
-
Diameter of spherical protein in neutral buffer solution(angstrom)=2.523×(molecular weight)0.3267 - (6) Average Pore Diameter
- The above-described correlation equation of a diameter and a molecular weight of a spherical protein in a neutral buffer solution was substituted with the molecular weight which corresponded to a value of [the maximum Kav]/2 in the portion showing linearity, and the calculated value was defined as the average diameter of the pores of sample particles.
- Additionally, when a value of Kav of the adsorbent for a target substance to be adsorbed is measured, an accurate measurement may possibly become impossible due to an adsorption of the target substance to be adsorbed on the adsorbent. Accordingly, a value of Kav of the adsorbent for a target substance to be adsorbed was determined by measuring values of Kav of two or more kinds of proteins having molecular weights close to that of a target substance to be adsorbed and carrying out calculation from the obtained data. For example, when a target substance to be adsorbed was IgG, a value of Kav was determined from data of ferritin and albumin.
- A median diameter was measured by using a laser diffraction/scattering particle size distribution analyzer (LA-950, manufactured by Horiba Ltd.). The measured value was defined as an average particle diameter.
- A static binding capacity was determined by the following procedures:
- a solution was obtained by dissolving 70 mg of human polyclonal IgG (0.467 mL of 1500 mg/10 mL Gamma-Globulin NICHIYAKU, produced by Nichiyaku) in a phosphate buffer (produced by Sigma) having a pH of 7.4 and adjusting the entire amount to be 35 mL;
- the above solution was brought into contact with 0.5 mL of the adsorbent of which solvent was substituted with a phosphate buffer (produced by Sigma) having a pH of 7.4;
- the mixture was stirred at 25° C. for 2 hours; and
- the decreased amount of IgG in the supernatant was measured.
- (1) Preparation of Solution
- The following solutions were prepared.
- A solution: a phosphate buffer having a pH of 7.4 (produced by Sigma)
B solution: 35 mM sodium acetate having a pH of 3.5 (prepared from acetic acid and sodium acetate produced by Nacalai Tesque, Inc. and RO water)
C solution: 1 M acetic acid (prepared from acetic acid produced by Nacalai Tesque, Inc. and RO water)
D solution: 1 mg/mL human polyclonal IgG solution (prepared from 1500 mg/10 mL Gamma-Globulin NICHIYAKU, produced by Nichiyaku and the A solution)
E solution: 6M urea (prepared from urea produced by KANTO CHEMICAL CO., INC. and RO water) - The respective solutions were defoamed before use.
- (2) Packing and Preparation
- As a column chromatography apparatus, AKTA explorer 100 (manufactured by GE Healthcare Bioscience) was used. A mesh of 22 μm was attached to a column having a diameter of 0.5 cm and a height of 15 cm. Into the column, 3 mL of each adsorbent of the present invention was loaded and packed by passing a 20% ethanol aqueous solution (prepared from ethanol produced by Wako Pure Chemical Industries, Ltd. and RO water) at a linear rate of 450 cm/hr for 1 hour. Sampling tubes having a volume of 15 mL were set to a fraction collector, and sampling tubes for an effluent were previously filled with the neutralizing solution.
- (3) Purification of IgG
- The A solution in an amount of 9 mL was allowed to pass at a linear rate of 300 cm/hr and subsequently, while monitoring UV, the D solution was allowed to pass at a linear rate of 300 cm/hr until 10% of IgG was eluted. Next, 30 mL of the A solution was allowed to pass at a linear rate of 300 cm/hr and 30 mL of the B solution was allowed to pass at a linear rate of 300 cm/hr to elute IgG. Subsequently, 9 mL of the C solution was allowed to pass at linear rate of 300 cm/hr and 9 mL of the E solution was allowed to pass at linear rate of 300 cm/hr.
- A slurry containing 50 vol % of the porous particle or the adsorbent was loaded to a graduated cylinder which was made of glass and which had an inner diameter of 15 mm. The porous particle or adsorbent was deposited to be packed until the volume of the porous particle or adsorbent was not further decreased by applying vibration to the graduated cylinder made of glass, and the amount of the porous particle or adsorbent was adjusted as to set the volume of the porous particle or adsorbent to be 4 mL. The volume at the time was defined as the initial volume. A piston made of a metal (which did not cause friction with the inner wall of the graduated cylinder and was processed to prevent elution of the porous particle or adsorbent) was attached to an autograph (EZ-TEST, manufactured by SHIMADZU CORPORATION) equipped with a load cell for 20N. The position of the piston was adjusted so that the bottom surface of the piston was moved to the position corresponding to 120 vol % of the porous particle or adsorbent. The piston was lowered at a testing rate of 5 mm/min in a manner of preventing entrainment of bubbles, and the porous particle or adsorbent was compressed and the volume was decreased. The compressive stress at arbitrary positions was measured.
- Crystalline cellulose (2.73 g) was dissolved in 1-ethyl-3-methylimidazolium acetate (produced by Sigma Aldrich, 20 g) at 70° C. to prepare a 12.0 wt % solution. From the cellulose solution, an amount of 15 mL was measured to be taken out. The measured amount of the solution was added to medium chain fatty acid triglyceride (MCT) (Acta M-2, fatty acid composition: 100% of C8, 85 mL, produced by Riken Vitamin Co., Ltd.) that was stirred at a rate of 4000 rpm by a homogenizer (HG-200, manufactured by HSIANGTAI). The cellulose solution was dispersed in MCT by stirring for 5 minutes. The dispersion was gradually added to water at 25° C. that was stirred at a rate of 300 rpm to solidify the cellulose. The dispersion was settled to separate a liquid phase. As a result, a bilayer solution composed of an upper layer containing MCT and a lower layer containing water and 1-ethyl-3-methylimidazolium acetate was observed. The cellulose was deposited in the lower layer.
- The cellulose was recovered and washed with methanol and thereafter washed with water. It was found by observation with a microscope (Digital Microscope VH-6200, manufactured by Keyence Corporation) that particulate cellulose was obtained.
- The microscopic image of the obtained particles was analyzed by using a commercially available image analyzing processing software (Motic Images Plus, manufactured by Motic) to measure an average aspect ratio. The average aspect ratio was determined by calculating the aspect ratio of each particle from the measured major axis and minor axis of the particles in the image and calculating the average of the calculated ratios. A median diameter was measured by using a laser diffraction/scattering particle size distribution analyzer (LA-950, manufactured by Horiba Ltd.) and employed the measured value as an average particle diameter. As a result, it was proved that fine cellulose particles with complete sphericity and having an average particle diameter of 104.0 μm and an average aspect ratio of 1.10 were obtained.
- The hardness of the cellulose particle was evaluated by measuring the compressive strength with the use of a compressive strength testing apparatus (EZ-TEST, manufactured by SHIMADZU CORPORATION). As a result, when the volume was compressed by 10%, the stress was 0.042 Mpa and it was apparent that the cellulose particle had proper hardness.
- Further, the inside of the pores of the obtained cellulose particles was replaced with 2-methyl-2-propanol, and the obtained cellulose particles were dried by freeze drying and then analyzed with a scanning electron microscope (S-800, manufactured by Hitachi Ltd., hereinafter referred to as “SEM”). As a result, the cellulose particles were confirmed to be porous particles as shown in
FIGS. 1 to 4 . - In addition, the dried cellulose particles were analyzed by powder x-ray diffraction (XRD, Rigaku Mini Flex II, the same applies hereinafter). The results are shown in
FIG. 5 . As shown inFIG. 5 , it was confirmed that the cellulose particles were crystalline. - Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 10.0 wt %. As a result, cellulose particles having an average particle diameter of 121.4 μm and an average aspect ratio of 1.12 were obtained. When the cellulose volume was compressed by 10%, the stress was 0.015 Mpa. The obtained particles were porous particles similar to those of the Comparative Example 1.
- Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 7.0 wt %. As a result, cellulose particles having an average particle diameter of 104.0 μm and an average aspect ratio of 1.10 were obtained. When the cellulose volume was compressed by 10%, the stress was 0.004 Mpa. The obtained particles were porous particles similar to those of the Comparative Example 1.
FIG. 5 shows the result of analysis of the cellulose particles of the Comparative Examples 1 to 3 by XRD, and it could be confirmed that all particles were crystalline and thus, it could be judged that the cellulose particles obtained from water had crystallinity. - Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 12.0 wt % and the cellulose-insoluble liquid was changed to a mixed solvent of methanol and water at a ratio of methanol:water=7:3. After the cellulose precipitation, the mixture was settled to give a bilayer solution composed of a lower layer containing MCT and an upper layer containing methanol, water, 1-ethyl-3-methylimidazolium acetate and MCT. The precipitated cellulose was deposited in the upper layer. The cellulose was recovered, and it was found that the obtained cellulose was spherical cellulose particle having an average particle diameter of 98.5 μm and an average aspect ratio of 1.07. As shown in SEM photographs of
FIGS. 6 to 9 , the particles were porous. - Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 12.0 wt % and the cellulose-insoluble liquid was changed to a mixed solvent of methanol and water at a ratio of methanol:water=9:1. After the cellulose precipitation, the mixture was settled to give a bilayer solution composed of a lower layer containing MCT and an upper layer containing methanol, water, 1-ethyl-3-methylimidazolium acetate and MCT. The precipitated cellulose was deposited in the upper layer. The cellulose was recovered, and it was found that the obtained cellulose was spherical cellulose particle having an average particle diameter of 97.3 μm and an average aspect ratio of 1.07. As shown in SEM photographs of
FIGS. 10 to 13 , the particles were porous. - Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose-insoluble liquid was changed to methanol. After a cellulose droplet dispersion was added to methanol in order to precipitate cellulose, the solution was settled to give a bilayer solution composed of a lower layer containing MCT and an upper layer containing methanol, 1-ethyl-3-methylimidazolium acetate and MCT. The precipitated cellulose was deposited in the upper layer. The cellulose was recovered, and it was found that the obtained cellulose was spherical cellulose particle having an average particle diameter of 60.4 μm and an average aspect ratio of 1.07.
- When the cellulose volume was compressed by 10%, the stress was 0.053 Mpa.
- As shown in SEM photographs of
FIGS. 14 to 17 , the particles were porous. - After freeze drying, XRD analysis was carried out to find that the obtained cellulose particles were amorphous.
FIG. 18 shows the results of XRD analysis for the cellulose particles obtained in the Comparative Example 1 and Examples 1 to 3, and it could be judged that the cellulose particles were amorphous, except those obtained by using water as a solidification liquid in the Comparative Example 1. - When the used solvents were recovered and methanol was evaporated using an evaporator, 1-ethyl-3-methylimidazolium acetate and MCT were separated. After MCT was removed, the volume and weight of 1-ethyl-3-methylimidazolium acetate were measured to find that the concentration of 1-ethyl-3-methylimidazolium acetate was 98%. The ionic liquid with high purity obtained as described above can sufficiently be reused.
- Cellulose particles were precipitated in the same condition and same manner as in the Example 3, except that the cellulose concentration was changed to 10.0 wt %. As a result, obtained were spherical cellulose particles having an average particle diameter of 54.23 μm and an average aspect ratio of 1.07. When the cellulose volume was compressed by 10%, the stress was 0.027 Mpa.
- Cellulose particles were precipitated in the same condition and same manner as in the Example 3, except that the cellulose concentration was changed to 7.0 wt %. As a result, obtained were spherical cellulose particles having an average particle diameter of 60.36 μm and an average aspect ratio of 1.07.
FIG. 19 shows the results of XRD analysis for the cellulose particles obtained in the Examples 3 to 5, and all of the cellulose particles were amorphous. - Cellulose particles were precipitated in the same condition and same manner as in the Comparative Example 1, except that the cellulose concentration was changed to 12.0 wt % and the cellulose-insoluble liquid was changed to ethanol. As a result, obtained were spherical cellulose particles having an average particle diameter of 87.44 μm and an average aspect ratio of 1.07. Different from the case of using water or methanol, in the case of using ethanol, the solution was not separated into two layers.
- When the cellulose volume was compressed by 10%, the stress was 0.026 Mpa.
- After freeze drying, XRD analysis was carried out to find that the obtained cellulose particles were amorphous. From
FIGS. 5 and 19 , it was found that the crystallinity of the cellulose particles was independent of the cellulose solution concentration and that the cellulose particles became amorphous in the case of using an alcohol as the cellulose-insoluble liquid and became crystalline in the case of using water. The crystallinity of the cellulose particles could be controlled depending on the kind of the cellulose-insoluble liquid. - Crystalline cellulose (5.80 g) was dissolved in 1-ethyl-3-methylimidazolium acetate (52.18 g) at 70° C. to prepare a 10.0 wt % solution. From the cellulose solution, a volume of 50 mL was measured to be taken out. The measured amount of the solution was added to 950 mL of MCT that was stirred at a rate of 100 rpm by an H type blade having a blade diameter of 70 mm in a cylindrical container having an inner diameter of 113 mm, in order to be dispersed. The temperature of the dispersion was adjusted to be 40° C., and the dispersion was allowed to pass at a rate of 1 L/minute through a static mixer (Bunsankun 1.5A, manufactured by Fujikin). Then, the dispersion was added to a mixed solvent of methanol and water at a ratio of methanol:water=9:1, which was a cellulose-insoluble liquid, to precipitate the cellulose. The mixed solvent of methanol:water=9:1 was stirred at a rate of 300 rpm by a flat turbine blade having a blade diameter of 64.2 mm in a cylindrical container having an inner diameter of 143.5 mm, and the solution volume was adjusted to be 2000 mL and the solution temperature was adjusted to be 25° C. The cellulose was recovered and washed with methanol and thereafter washed with water. Similarly to the Comparative Example 1, the obtained cellulose was observed with a microscope to find that obtained were cellulose particles having an average particle diameter of 86.3 μm and an average aspect ratio of 1.07. As shown in SEM photographs of
FIGS. 20 and 21 , the particles were porous. - Crystalline cellulose in an amount of 2.73 g was dissolved in a solution obtained by adding 2.22 g of a mixed solution of methanol and water at a ratio of methanol:water=7:3 to 20 g of 1-ethyl-3-methylimidazolium acetate (produced by Sigma Aldrich). The cellulose concentration in the solution was 10.9 wt %. From the cellulose solution, a volume of 15 mL was measured to be taken out. The measured amount of the solution was added to 85 mL of medium chain fatty acid triglyceride (MCT) (trade name: Acta M-2, fatty acid composition: 100% of C8, produced by Riken Vitamin Co., Ltd.) that was stirred at a rate of 400 rpm at 50° C. After the cellulose solution was dispersed in MCT by stirring for 30 minutes, the cellulose droplet dispersion was added to 400 mL of a mixed solvent of methanol and water at a ratio of methanol:water=7:3 that was stirred at 300 rpm at 50° C. to solidify cellulose.
- After the mixture was stirred for 30 minutes, cellulose particles were recovered and washed with ethanol and thereafter washed with water. Next, the cellulose particles were classified using a mesh of 125 μm to remove particles having a large particle diameter, and then classified using a mesh of 53 μm to remove particles having a small particle diameter. Further, a portion of the obtained cellulose particles was taken out, and the solvent thereof was substituted with 2-methyl-2-propanol. The obtained cellulose particles were dried by freeze drying, and then analyzed with a scanning electron microscope (S-4800, manufactured by Hitachi Ltd., hereinafter referred to as “SEM”). As a result, the cellulose particles were confirmed to be porous particles as shown in
FIG. 22 . - The fine pore diameter of the obtained cellulose porous particles was determined by the above-described Kav measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 725 angstroms and 271 angstroms, respectively. The inclination k was −0.153. A value of K, measured by using IgG was 0.86. The exclusion limit molecular weight was 3.5×107. Further, the dried cellulose particles were analyzed by powder x-ray diffraction (XRD, Rigaku Mini Flex II, the same applies hereinafter), and the result showed an amorphous pattern. The average particle diameter was 94 μm.
- Cellulose particles were obtained in the same condition as in the Example 8, except that the temperature of MCT was changed to 25° C. and the temperature of the mixed solvent of methanol:water=7:3 was changed to 25° C. As the result of analysis by SEM, the obtained cellulose particles were confirmed to be porous particles as shown in
FIG. 23 . The fine pore diameter of the obtained cellulose porous particles was determined by the above-described Kav measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 350 angstroms and 194 angstroms, respectively. The inclination k was −0.266. The value of Kav measured by using IgG was 0.93. The exclusion limit molecular weight was 3.8×106. The average particle diameter was 88 μm. - Cellulose particles were obtained in the same condition as in the Example 8, except that the temperature of MCT was changed to 10° C. and the temperature of the mixed solvent of methanol:water=7:3 was changed to 10° C. As the result of analysis by SEM, the obtained cellulose particles were confirmed to be porous particles as shown in
FIG. 24 . The average particle diameter was 83 μm.FIG. 25 shows the results of XRD analysis for the cellulose particles obtained in the Examples 8 to 10, and all of the cellulose particles were amorphous. - Cellulose particles were obtained in the same condition as in the Example 9, except that 2.22 g of a mixed solution of methanol and water at a ratio of methanol:water=6:4 was added to 20 g of 1-ethyl-3-methylimidazolium acetate (produced by Sigma Aldrich) and that the cellulose droplet dispersion was added to 400 mL of a cellulose-insoluble liquid which was a mixed solvent of methanol and water at a ratio of methanol:water=6:4. As the result of analysis by SEM, the obtained cellulose particles were confirmed to be porous particles similar to the particles of the Example 9. The fine pore diameter of the obtained cellulose porous particles was determined by the above-described Kav measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 362 angstroms and 201 angstroms, respectively. The inclination k was −0.222. The value of Kav measured by using IgG was 0.80. The exclusion limit molecular weight was 4.2×106. XRD analysis was carried out to find that the obtained cellulose particles were amorphous. The average particle diameter was 90 μm.
- Cellulose particles were obtained in the same condition as in the Example 9, except that 2.22 g of a mixed solvent of methanol and water at a ratio of methanol:water=9:1 was added to 20 g of 1-ethyl-3-methylimidazolium acetate (produced by Sigma Aldrich) and that the cellulose droplet dispersion was added to 400 mL of a cellulose-insoluble liquid which was a mixed solvent of methanol and water at a ratio of methanol:water=9:1. As the result of analysis by SEM, the obtained cellulose particles were confirmed to be porous particles similar to the particles of the Example 9. The fine pore diameter of the obtained cellulose porous particles was determined by the above-described Kav measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 261 angstroms and 184 angstroms, respectively. The inclination k was −0.380. The value of Kav measured by using IgG was 0.86. The exclusion limit molecular weight was 1.5×106. XRD analysis was carried out to find that the obtained cellulose particles were amorphous. The average particle diameter was 90 μm.
- Cellulose particles were obtained in the same condition as in the Example 9, except that 1.93 g of crystalline cellulose was dissolved in a solution obtained by adding 2.22 g of a mixed solvent of methanol and water at a ratio of methanol:water=7:3 to 20 g of 1-ethyl-3-methylimidazolium acetate (produced by Sigma Aldrich) and that the cellulose concentration was changed to 8.0 wt %. As the result of analysis by SEM, the obtained cellulose particles were confirmed to be porous particles similar to the particles of the Example 8. The fine pore diameter of the obtained cellulose porous particles was determined by the above-described Kav measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 1020 angstroms and 306 angstroms, respectively. The inclination k was −0.117. The value of Kav measured by using IgG was 0.79. The exclusion limit molecular weight was 1.0×108. XRD analysis was carried out to find that the obtained cellulose particles were amorphous. The average particle diameter was 94 μm.
- Crystalline cellulose in an amount of 2.00 g was dissolved in 18.0 g of 1-ethyl-3-methylimidazolium acetate to obtain a solution having a cellulose concentration of 10.0 wt %. From the cellulose solution, a volume of 15 mL was measured to be taken out. The measured amount of the solution was added to 85 mL of MCT that was stirred at a rate of 400 rpm at 25° C. After the cellulose solution was dispersed in MCT by stirring for 30 minutes, the cellulose droplet dispersion was added to 400 mL of a mixed solvent of methanol and water at a ratio of methanol:water=7:3 that was stirred at 300 rpm at 25° C. to solidify cellulose.
- After the mixture was stirred for 30 minutes, cellulose particles were recovered and washed with ethanol and thereafter washed with water.
- The fine pore diameter of the obtained cellulose porous particles was determined by the above-described Kav measurement method; as a result, the maximum fine pore diameter and average diameter of the cellulose porous particles were found to be 1340 angstroms and 353 angstroms, respectively. The inclination k was −0.102. The value of Kav measured by using IgG was 0.78. The exclusion limit molecular weight was 2.3×108.
- From the cellulose porous particles obtained in the Example 8, coarse porous particles were removed by using a sieve having an opening of 125 μm, and then too small porous particles were removed by using a sieve having an opening of 53 μm. RO water was added to 11.0 mL of the cellulose porous particles A after the classification operation to adjust the volume to be 16.5 mL, and the mixture was transferred to a 50 mL centrifugal tube. Further, 3.86 mL of 4N NaOH (prepared from NaOH produced by Nacalai Tesque, Inc. and RO water) was added thereto and the obtained mixture was heated to 40° C. in a hybridization oven (MHS-2000, manufactured by TOKYO RIKAKIKAI CO., LTD.). To the mixture, 1.77 g of Denacol EX-314 containing glycerol polyglycidyl ether (produced by Nagase ChemteX Corporation) was added as a crosslinking agent. The mixture was stirred at 40° C. for 4 hours. After the completion of the reaction, while carrying out filtration under reduced pressure on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), the obtained porous particles were washed with RO water in a volume of 20 times as much as that of the obtained porous particles, to obtain crosslinked porous particles. - RO water was added to the obtained crosslinked porous particles to increase the total volume to 10 times as much as that of the crosslinked porous particles, and the mixture was sealed with two sheets of an aluminum foil and heated at 120° C. for 1 hour by using an autoclave (High pressure sterilizer ES-315, manufactured by TOMY SEIKO CO., LTD.). The mixture was allowed to cool down to room temperature, and then the porous particles were washed with RO water in a volume of 5 times as much as that of the porous particles on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), to obtain autoclaved porous particles B of which epoxy groups were transformed into glyceryl groups. - Next, RO water was added to the autoclaved porous particles B (10 mL) to adjust the volume to be 16.5 mL, and the mixture was transferred to a 50 mL centrifugal tube. Further, 3.86 mL of 4N NaOH (prepared from NaOH produced by Nacalai Tesque, Inc. and RO water) was added thereto, and the obtained mixture was heated to 40° C. in a hybridization oven (MHS-2000, manufactured by TOKYO RIKAKIKAI CO., LTD.). Then, 1.77 g of Denacol EX-314 (produced by Nagase ChemteX Corporation) was added thereto, and the mixture was stirred at 40° C. for 4 hours. After the completion of the reaction, while carrying out filtration under reduced pressure on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), the obtained porous particles were washed with RO water in a volume of 20 times as much as that of the obtained porous particles, to obtain crosslinked porous particles. - RO water was added to the obtained crosslinked porous particles to increase the total volume to 10 times as much as that of the crosslinked porous particles, and the mixture was put into an Erlenmeyer flask (300 mL) made of glass. The flask was sealed with two sheets of an aluminum foil, and the mixture was heated at 120° C. for 60 minutes by using an autoclave (High pressure sterilizer ES-315, manufactured by TOMY SEIKO CO., LTD.). The mixture was allowed to cool down to room temperature, and then the porous particles were washed with RO water in a volume of 5 times as much as that of the porous particles on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), to obtain autoclaved porous particles C. - Further, RO water was added to the autoclaved porous particles C (10.5 mL) to adjust the volume to be 15.8 mL, and the mixture was transferred to a 50 mL centrifugal tube. Further, 2.68 mL of 4N NaOH (prepared from NaOH produced by Nacalai Tesque, Inc. and RO water) was added thereto, and the obtained mixture was heated to 40° C. in a hybridization oven (MHS-2000, manufactured by TOKYO RIKAKIKAI CO., LTD.). Then, 1.69 g of Denacol EX-314 (produced by Nagase ChemteX Corporation) was added thereto, and the mixture was stirred at 40° C. for 4 hours. After the completion of the reaction, while carrying out filtration under reduced pressure on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), the obtained porous particles were washed with RO water in a volume of 20 times as much as that of the obtained porous particles, to obtain crosslinked porous particles. - RO water was added to the obtained crosslinked porous particles to increase the total volume to 10 times as much as that of the crosslinked porous particles, and the mixture was put into an Erlenmeyer flask (300 mL) made of glass. The flask was sealed with two sheets of an aluminum foil, and the mixture was heated at 120° C. for 60 minutes by using an autoclave (High pressure sterilizer ES-315, manufactured by TOMY SEIKO CO., LTD.). The mixture was allowed to cool down to room temperature, and then the porous particles were washed with RO water in a volume of 5 times as much as that of the porous particles on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), to obtain autoclaved porous particles D. - RO water was added to 11.0 mL of the crosslinked porous particles D obtained in the Example 15 to adjust the total volume to be 17.0 mL. The mixture was transferred to a 50 mL centrifugal tube. The centrifugal tube was installed in a mix rotor (Mix Rotor MR-3, manufactured by AS ONE Corporation) and the mixture was stirred at 25° C. Next, 6.0 mL of a 8.64 mg/mL sodium periodate aqueous solution was prepared by dissolving sodium periodate (produced by Wako Pure Chemical Industries, Ltd.) in RO water and added to the centrifugal tube containing the porous particles D. The mixture was stirred at 25° C. for 1 hour. After the reaction, the porous particles were washed with RO water on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.) until the electric conductivity of the filtrate became not more than 1 μS/cm, to obtain a formyl group-crosslinked porous carrier E. The electric conductivity of the washing filtrate was measured by a conductivity meter (ECTester 10 Pure+, manufactured by EUTECH INSTRUMENTS). A formyl group content in the obtained porous particles E was measured by the above-described method to find that the formyl group content was 20.17 μmol per 1 mL of the porous particles E. - The solvent of the obtained formyl-crosslinked porous carrier E (9.0 mL) was substituted with 30 mL of a buffer of which pH was 11 and which contained 0.5 M trisodium citrate (produced by KANTO CHEMICAL CO., INC.) and 0.15 M sodium chloride (produced by KANTO CHEMICAL CO., INC.) on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.). The formyl group-containing porous carrier after substitution was put into a centrifugal tube, and the amount was adjusted to be 14.0 mL in total by volume. After 5.327 g of a protein A-containing solution (PNXL 30, produced by KANEKA CORPORATION) which was produced by the method disclosed in WO 2006/004067 and of which concentration of protein A was 67.58 mg/mL was added thereto, the pH was adjusted to be 12 by using 0.08N NaOH (prepared from one produced by Nacalai Tesque, Inc. and RO water) at 6° C. Then, the mixture was stirred at 6° C. for 23 hours by using a mix rotor (Mix Rotor MR-3, manufactured by AS ONE Corporation) to progress a reaction. - After the reaction for 23 hours, the pH of the reaction mixture was adjusted to be 5.0 by using 2.4 N citric acid (prepared from citric acid produced by KANTO CHEMICAL CO., INC. and RO water), and then the mixture was stirred at 6° C. for 4 hours by using a mix rotor (Mix Rotor MR-3, manufactured by AS ONE Corporation). Continuously, 0.39 mL of a 5.5% dimethylamine borane (DMAB) aqueous solution (prepared from dimethylamine borane produced by Kishida Chemical Co., Ltd. and RO water) was added thereto, and the mixture was stirred at 6° C. for 1 hour. Then, the reaction temperature was increased to 25° C. and the mixture was stirred at 25° C. for 18 hours using a mix rotor (Mix Rotor MR-3, manufactured by AS ONE Corporation) to carry out a reaction. After the completion of the reaction, the maximum UV absorbance of the reaction mixture around 278 nm was measured to find that the amount of the protein A as an affinity ligand to be introduced was 28.93 mg per 1 mL of the porous carrier.
- The porous carrier after the reaction was washed with RO water in a volume of 3 times as much as that of the porous carrier on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.). Next, 0.1 N citric acid monohydrate (prepared from citric acid monohydrate produced by KANTO CHEMICAL CO., INC. and RO water) in a 3 times amount by volume was added, and further 0.1 N citric acid monohydrate was added to the porous carrier to adjust the total volume to be not less than 30 mL. The mixture was put into a centrifugal tube and washed with an acid while stirred at 25° C. for 30 minutes. - After the above acid washing, the porous carrier was washed with RO water in a volume of 3 times as much as that of the porous carrier on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.), and thereafter an aqueous solution of 0.05 M sodium hydroxide and 1 M sodium sulfate (prepared from sodium hydroxide produced by Nacalai Tesque, Inc., sodium sulfate produced by KANTO CHEMICAL CO., INC., and RO water) was added in a 3 times amount by volume. Next, an aqueous solution of 0.05 M sodium hydroxide and 1 M sodium sulfate was added to the porous carrier so as that the total volume was adjusted to be not lower than 30 mL. The mixture was put into a centrifugal tube and washed with alkali while stirred at room temperature for 30 minutes. - After the above alkali washing, the porous carrier was washed with RO water in a volume of 20 times as much as that of the porous carrier on a glass filter (
11GP 100, manufactured by SIBATA SCIENTIFIC TECHNOLOGY LTD.). Next, 0.1 N citric acid monohydrate (prepared from citric acid monohydrate produced by KANTO CHEMICAL CO., INC. and RO water) in a volume of 3 time as much as that of the porous carrier was added, and it was confirmed that the filtrate became neutral. Then, the porous carrier was washed by using RO water until the electric conductivity of the washing filtrate became not more than 1 μS/cm, to obtain an adsorbent F as a target adsorbent on which a protein A was immobilized. The electric conductivity of the washing filtrate was measured by a conductivity meter (ECTester 10 Pure+, manufactured by EUTECH INSTRUMENTS). - As a target substance to be adsorbed by the obtained adsorbent, human polyclonal IgG (1500 mg/10 mL Gamma-Globulin Nichiyaku, produced by Nichiyaku) was selected, and the static binding capacity was measured. As a result, the static binding capacity was 83.9 mg/mL for the adsorbent. Further, the dynamic binding capacity was measured to find that the IgG adsorption capacity (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 29.8 mg/mL for the adsorbent. Further, the IgG adsorption capacity (5% dynamic binding capacity) at a linear rate of 150 cm/hour was 36.0 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 9 was used. The static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 85.9 mg/mL for the adsorbent. Further, the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 6.9 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 10 was used. The static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 49.3 mg/mL for the adsorbent. Further, the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 1.6 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 11 was used. The static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 79.3 mg/mL for the adsorbent. Further, the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 9.3 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 12 was used. The static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 58.9 mg/mL for the adsorbent. Further, the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 1.6 mg/mL for the adsorbent.
- An adsorbent on which protein A was immobilized was obtained in the same manner as in the Examples 15 and 16, except that the cellulose porous particle obtained in the Example 13 was used. The static binding capacity of the obtained adsorbent was measured; as a result, the static binding capacity was 83.9 mg/mL for the adsorbent. Further, the dynamic adsorption amount was measured to find that the IgG dynamic adsorption amount (5% dynamic binding capacity) at a linear rate of 300 cm/hour was 12.8 mg/mL for the adsorbent.
Claims (20)
1. A method for producing a porous particle, comprising the steps of:
preparing a solution containing cellulose and an ionic liquid;
preparing a dispersion by dispersing the obtained cellulose solution into a liquid, wherein the liquid is not compatible with the ionic liquid; and
coagulating the dispersion by bringing into contact with an alcohol or an alcohol aqueous solution in order to obtain the porous particle.
2. The production method according to claim 1 , wherein water and/or an alcohol is added and an amount of the water and/or alcohol to be added is adjusted to be not less than 2 wt % and not more than 20 wt % relative to a total amount with the ionic liquid in the step for preparing the cellulose solution.
3. The production method according to claim 1 , wherein a temperature of the cellulose solution is adjusted to be not less than 0° C. and not more than 70° C.
4. The production method according to claim 1 , wherein the dispersion is brought into contact with the alcohol or the alcohol aqueous solution under the condition of not less than 10° C.
5. A porous particle, produced by the method according to claim 1 .
6. The porous particle according to claim 5 , wherein a value of k is not more than −0.1 under the condition that the following formula (I) holds when the porous particle is packed in a column, partition coefficients of multiple proteins having equal or higher molecular weight as compared to a target substance to be adsorbed are measured, and measured values are plotted with Kav values on an abscissa and logarithm values of the molecular weights on an ordinate:
K av =k×ln(MW)+b (I)
K av =k×ln(MW)+b (I)
wherein Kav represents the partition coefficient, MW represents the molecular weight of the protein, and b represents a constant.
7. The porous particle according to claim 6 , wherein the Kav value of the target substance to be adsorbed measured by using the column packed with the porous particle is not less than 0.3.
8. The porous particle according to claim 6 , wherein the Kav value of IgG measured by using the column packed with the porous particle is not less than 0.3.
9. The porous particle according to claim 5 , wherein an exclusion limit molecular weight is not less than 103 and not more than 109.
10. An adsorbent, comprising an affinity ligand and the porous particle produced by the method comprising the steps of: preparing a solution containing cellulose and an ionic liquid; preparing a dispersion by dispersing the obtained cellulose solution into a liquid, wherein the liquid is not compatible with the ionic liquid; and coagulating the dispersion by bringing into contact with an alcohol or an alcohol aqueous solution in order to obtain the porous particle or the porous particle according to claim 5 , wherein the affinity ligand is immobilized on the porous particle.
11. The adsorbent according to claim 10 , wherein an amount of the affinity ligand to be introduced is not less than 1 mg and not more than 1000 mg per ml of the porous particle.
12. The adsorbent according to claim 10 , wherein an amount of cellulose to be contained is not less than 2 wt % and not more than 50 wt %.
13. The adsorbent according to claim 10 , wherein the porous particle is cross-linked.
14. The adsorbent according to claim 10 , wherein a compressive stress when the adsorbent is compressed by 10% is not less than 0.01 MPa and not more than 3 MPa.
15. The adsorbent according to claim 10 , wherein a volume average particle diameter is not less than 1 μm and not more than 2000 μm.
16. The adsorbent according to claim 10 , wherein the affinity ligand is protein A.
17. A method for purifying a protein, comprising the steps of:
packing the adsorbent according to claim 10 into a column;
allowing a solution containing a crude protein to pass through the adsorbent packed in the column; and
allowing an eluent to pass through the column.
18. The production method according to claim 2 , wherein a temperature of the cellulose solution is adjusted to be not less than 0° C. and not more than 70° C.
19. The production method according to claim 2 , wherein the dispersion is brought into contact with the alcohol or the alcohol aqueous solution under the condition of not less than 10° C.
20. The production method according to claim 3 , wherein the dispersion is brought into contact with the alcohol or the alcohol aqueous solution under the condition of not less than 10° C.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010-203774 | 2010-09-10 | ||
| JP2010203774 | 2010-09-10 | ||
| JP2010234060 | 2010-10-18 | ||
| JP2010-234060 | 2010-10-18 | ||
| PCT/JP2011/070757 WO2012033223A1 (en) | 2010-09-10 | 2011-09-12 | Method for producing porous particles, porous particles, adsorbent body, and method for purifying protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20130172538A1 true US20130172538A1 (en) | 2013-07-04 |
Family
ID=45810811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/821,836 Abandoned US20130172538A1 (en) | 2010-09-10 | 2011-09-12 | Method for producing porous particles, porous particles, adsorbent body, and method for purifying protein |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20130172538A1 (en) |
| EP (1) | EP2626381A4 (en) |
| JP (1) | JP5785553B2 (en) |
| WO (1) | WO2012033223A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106062055A (en) * | 2014-03-12 | 2016-10-26 | 富士胶片株式会社 | Method for producing porous cellulose particles, and porous cellulose particles |
| US10189007B2 (en) | 2013-10-15 | 2019-01-29 | Kaneka Corporation | Method for producing porous cellulose beads and adsorbent employing same |
| CN111286049A (en) * | 2020-03-02 | 2020-06-16 | 青岛科技大学 | A kind of cellulose porous spherical crystal microsphere and preparation method thereof |
| CN115125030A (en) * | 2022-08-11 | 2022-09-30 | 东北石油大学 | A kind of polyethylene glycol porous ionic liquid and its preparation method and application |
| US11685793B2 (en) | 2013-09-02 | 2023-06-27 | Jnc Corporation | Method for producing porous cellulose particles, and porous cellulose particles |
| US11806421B2 (en) | 2018-06-29 | 2023-11-07 | Jgc Catalysts And Chemicals Ltd. | Porous-cellulose particles and production method thereof, and cosmetic |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5578015B2 (en) * | 2010-10-19 | 2014-08-27 | Jsr株式会社 | Method for producing cellulose particles, and cellulose particles |
| JP6506554B2 (en) * | 2012-09-10 | 2019-04-24 | 株式会社カネカ | Adsorbent and purification method using the same |
| JP6148033B2 (en) * | 2013-02-22 | 2017-06-14 | 旭化成株式会社 | Cellulose microparticles containing fluorescent dye compounds |
| JP6081852B2 (en) * | 2013-04-12 | 2017-02-15 | 株式会社Kri | Method for producing polysaccharide porous body |
| WO2015056680A1 (en) * | 2013-10-15 | 2015-04-23 | 株式会社カネカ | Method for manufacturing porous cellulose beads |
| WO2016013568A1 (en) | 2014-07-22 | 2016-01-28 | 株式会社ダイセル | Method for producing porous cellulose medium |
| EP3284778A4 (en) * | 2015-04-15 | 2018-11-21 | Kaneka Corporation | Method for producing porous cellulose beads, and adsorbent using same |
| CN108350091A (en) * | 2015-10-30 | 2018-07-31 | 东丽株式会社 | Ether series fiber element derivative particle |
| CN105542217B (en) * | 2016-01-19 | 2019-01-29 | 青岛科技大学 | A kind of cellulose gel based material and preparation method thereof with gradient cavernous structure |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4435217A (en) * | 1982-04-22 | 1984-03-06 | Venture Innovations, Inc. | Concentrated hydrophilic polymer suspensions |
| US20080269477A1 (en) * | 2005-12-23 | 2008-10-30 | Basf Se | Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates |
| WO2009101111A1 (en) * | 2008-02-11 | 2009-08-20 | Basf Se | Method for producing porous structures from synthetic polymers |
| EP2103644A1 (en) * | 2007-01-12 | 2009-09-23 | Asahi Kasei Fibers Corporation | Cellulose fine particle, dispersion liquid thereof and dispersion body thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61211342A (en) * | 1985-03-15 | 1986-09-19 | Asahi Chem Ind Co Ltd | Manufacturing method of ultrafine polymer particles |
| JPH0730202B2 (en) * | 1986-10-11 | 1995-04-05 | ダイセル化学工業株式会社 | Manufacturing method of spherical particles |
| JP2646463B2 (en) * | 1992-01-08 | 1997-08-27 | 鐘紡株式会社 | Method for producing crosslinked porous ion exchange cellulose fine particles |
| DE19755352C1 (en) * | 1997-12-14 | 1999-06-24 | Thueringisches Inst Textil | Preparation of regular, porous pearl cellulose |
| CN1267486C (en) * | 2003-06-16 | 2006-08-02 | 东华大学 | Method for preparing nano-level cellulose granule |
| DE102006057904A1 (en) * | 2006-12-08 | 2008-06-12 | Dow Wolff Cellulosics Gmbh | Production of cellulose nanoparticles |
| US8153782B2 (en) * | 2007-02-14 | 2012-04-10 | Eastman Chemical Company | Reformation of ionic liquids |
| JP2008266401A (en) * | 2007-04-18 | 2008-11-06 | Nisshinbo Ind Inc | Cellulose molded body and method for producing the same |
| EP2022801B1 (en) * | 2007-08-10 | 2018-01-17 | Dow Global Technologies LLC | Nanoparticles made of amorphous cellulose |
| AT505904B1 (en) * | 2007-09-21 | 2009-05-15 | Chemiefaser Lenzing Ag | CELLULOSE SUSPENSION AND METHOD FOR THE PRODUCTION THEREOF |
| AT505905B1 (en) * | 2007-09-21 | 2009-05-15 | Chemiefaser Lenzing Ag | CELLULOSE POWDER AND METHOD FOR THE PRODUCTION THEREOF |
| JP5055314B2 (en) * | 2009-02-27 | 2012-10-24 | 株式会社日立製作所 | Cellulose / resin composite and method for producing the same |
| JP5894373B2 (en) * | 2010-03-19 | 2016-03-30 | 株式会社カネカ | Method for producing cellulose porous particles |
-
2011
- 2011-09-12 EP EP11823691.8A patent/EP2626381A4/en not_active Withdrawn
- 2011-09-12 US US13/821,836 patent/US20130172538A1/en not_active Abandoned
- 2011-09-12 JP JP2012533053A patent/JP5785553B2/en not_active Expired - Fee Related
- 2011-09-12 WO PCT/JP2011/070757 patent/WO2012033223A1/en not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4435217A (en) * | 1982-04-22 | 1984-03-06 | Venture Innovations, Inc. | Concentrated hydrophilic polymer suspensions |
| US20080269477A1 (en) * | 2005-12-23 | 2008-10-30 | Basf Se | Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates |
| EP2103644A1 (en) * | 2007-01-12 | 2009-09-23 | Asahi Kasei Fibers Corporation | Cellulose fine particle, dispersion liquid thereof and dispersion body thereof |
| US20100087552A1 (en) * | 2007-01-12 | 2010-04-08 | Yoshiyuki Shiomi | Cellulose fine particles, and liquid or solid dispersion thereof |
| WO2009101111A1 (en) * | 2008-02-11 | 2009-08-20 | Basf Se | Method for producing porous structures from synthetic polymers |
| US20100310853A1 (en) * | 2008-02-11 | 2010-12-09 | Stefan Schwiegk | Method for producing porous structures from synthetic polymers |
Non-Patent Citations (5)
| Title |
|---|
| Aaltonen et al. The preparation of lignocellulosic aerogels from ionic liquid solutions. Carbohydrate Polymers 75 (2009) 125-129. * |
| Aaltonen et al. The preparation of lignocellulosic aerogels from ionic liquid solutions. Carbohydrate Polymers 75 (2009) 125-129.Du et al. Preparation and characterization of novel macroporous cellulose beads regenerated from ionic liquid for fast chromatography. Journal of Chromatography A, 1217 (2010) 1298-1304. * |
| Morrison et al. WATER-SOLUBLE CELLULOSE ETHERS AS EMULSIFYING AGENTS. J.S.C.I. 1949; 68(12):333-336. * |
| Walter Jones. HIGH PRODUCTION VOLUME (HPV) CHEMICAL CHALLENGE PROGRAM TEST PLAN. The Pine Chemicals Association, Inc. 2001. * |
| Wheatley TA. Water soluble cellulose acetate: a versatile polymer for film coating. Drug Dev Ind Pharm. 2007 Mar;33(3):281-90. * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11685793B2 (en) | 2013-09-02 | 2023-06-27 | Jnc Corporation | Method for producing porous cellulose particles, and porous cellulose particles |
| US10189007B2 (en) | 2013-10-15 | 2019-01-29 | Kaneka Corporation | Method for producing porous cellulose beads and adsorbent employing same |
| CN106062055A (en) * | 2014-03-12 | 2016-10-26 | 富士胶片株式会社 | Method for producing porous cellulose particles, and porous cellulose particles |
| US11806421B2 (en) | 2018-06-29 | 2023-11-07 | Jgc Catalysts And Chemicals Ltd. | Porous-cellulose particles and production method thereof, and cosmetic |
| CN111286049A (en) * | 2020-03-02 | 2020-06-16 | 青岛科技大学 | A kind of cellulose porous spherical crystal microsphere and preparation method thereof |
| CN115125030A (en) * | 2022-08-11 | 2022-09-30 | 东北石油大学 | A kind of polyethylene glycol porous ionic liquid and its preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012033223A1 (en) | 2012-03-15 |
| JP5785553B2 (en) | 2015-09-30 |
| EP2626381A4 (en) | 2014-01-15 |
| EP2626381A1 (en) | 2013-08-14 |
| JPWO2012033223A1 (en) | 2014-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130172538A1 (en) | Method for producing porous particles, porous particles, adsorbent body, and method for purifying protein | |
| JP6506554B2 (en) | Adsorbent and purification method using the same | |
| US10457705B2 (en) | Carrier for ligand immobilization | |
| Monier et al. | Preparation of cross-linked chitosan/glyoxal molecularly imprinted resin for efficient chiral resolution of aspartic acid isomers | |
| JPH04505968A (en) | Coating media for chromatography | |
| EP1200186A1 (en) | Foamed material filled with inner material | |
| KR20140011337A (en) | Method for producing porous cellulose beads | |
| Parisi et al. | Surface modifications of molecularly imprinted polymers for improved template recognition in water media | |
| US10189007B2 (en) | Method for producing porous cellulose beads and adsorbent employing same | |
| EP3284778A1 (en) | Method for producing porous cellulose beads, and adsorbent using same | |
| JP2002523759A (en) | Hybrid substances and their use | |
| KR101333577B1 (en) | Process for making improved chromatography media and method of use | |
| Du et al. | Reversible Concanavalin A (Con A) ligands immobilization on metal chelated macroporous cellulose monolith and its selective adsorption for glycoproteins | |
| JP2003524680A (en) | Affinity control type material using stimulus-responsive polymer and separation / purification method using the material | |
| Zhang et al. | Covalently coating dextran on macroporous polyglycidyl methacrylate microsphere enabled rapid protein chromatographic separation | |
| WO2019220866A1 (en) | Porous cellulose beads and method for producing adsorbent | |
| EP3059251B1 (en) | Method for manufacturing porous cellulose beads | |
| Nova et al. | Elaboration, characterization and study of a new hybrid chitosan/ceramic membrane for affinity membrane chromatography | |
| Türkmen et al. | Megaporous poly (hydroxy ethylmethacrylate) based poly (glycidylmethacrylate-N-methacryloly-(l)-tryptophan) embedded composite cryogel | |
| Decompte | Aqueous dispersions of molecularly imprinted colloids for the detection of an organic micropollutant | |
| Fouad et al. | An insight into chiral monolithic stationary phases for enantioselective HPLC applications | |
| WO2018186222A1 (en) | Porous cellulose beads and adsorbent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: KANEKA CORPORATION, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HIRANO, MASARU;SUZUKI, YASUYUKI;KANAYA, KENTO;AND OTHERS;REEL/FRAME:029959/0842 Effective date: 20130305 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |